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Lymph nodes are essential organs of the immune system where adaptive immune responses 
originate, and consist of various leukocyte populations and a stromal backbone. Fibroblastic 
reticular cells (FRCs) are the main stromal cells and form a sponge-like extracellular matrix 
network, called conduits, which they themselves enwrap and contract. Lymph, containing 
soluble antigens, arrive in lymph nodes via afferent lymphatic vessels that connect to the 
subcapsular sinus and conduit network. According to the current paradigm, the conduit 
network distributes afferent lymph through lymph nodes and thus provides access for 
immune cells to lymph-borne antigens. An elastic capsule surrounds the organ and confines 
the immune cells and FRC network. Lymph nodes are completely packed with lymphocytes  
and lymphocyte numbers directly dictates the size of the organ. Although lymphocytes  
constantly enter and leave the lymph node, its size remains remarkedly stable under 
homeostatic conditions. It is only partly known how the cellularity and size of the lymph node 
is regulated and how the lymph node is able to swell in inflammation. The role of the FRC 
network in lymph node swelling and transfer of fluids are investigated in this thesis. 
Furthermore, we studied what trafficking routes are used by cancer cells in lymph nodes to 
form distal metastases. 
 
We examined the role of a mechanical feedback in regulation of lymph node swelling. Using 
parallel plate compression and UV-laser cutting experiments we dissected the mechanical 
force dynamics of the whole lymph node, and individually for FRCs and the capsule. Physical 
forces generated by packed lymphocytes directly affect the tension on the FRC network and 
capsule, which increases its resistance to swelling. This implies a feedback mechanism 
between tissue pressure and ability of lymphocytes to enter the organ. Following 
inflammation, the lymph node swells ∼10 fold in two weeks. Yet, what is the role for tension 
on the FRC network and capsule, and how are lymphocytes able to enter in conditions that 
resist swelling remain open questions. We show that tension on the FRC network is important 
to limit the swelling rate of the organ so that the FRC network can grow in a coordinated 
fashion. This is illustrated by interfering with FRC contractility, which leads to faster swelling 
rates and a disorganized FRC network in the inflamed lymph node. Growth of the FRC network 
in turn is expected to release tension on these structures and lowers the resistance to 
swelling, thereby allowing more lymphocytes to enter the organ and drive more swelling. Halt 
of swelling coincides with a thickening of the capsule, which forms a thick resistant band 
around the organ and lowers tension on the FRC network to form a new force equilibrium. 
 
The FRC and conduit network are further believed to be a privileged site of soluble 
information within the lymph node, although many details remain unsolved. We show by 3D 
ultra-reconstruction that FRCs and antigen presenting cells cover the surface of conduit 
system for more than 99% and we discuss the implications for soluble information exchange 
at the conduit level. 
 
Finally, there is an ongoing debate in the cancer field whether and how cancer cells in lymph 
nodes seed distal metastases. We show that cancer cells infused into the lymph node can 
utilize trafficking routes of immune cells and rapidly migrate to blood vessels. Once in the 
blood circulation, these cells are able to form metastases in distal tissues. 
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1  Introduction 
 
In this chapter we will explore the various facets of immunity. The immune system, its 
components and the immune response will be discussed in general before lymphoid organs 
and in specific the lymph node and the role of its stromal cells in immunity are discussed in 
more detail. 
1.1 The Immune System 
The immune system is a fascinating and complex system that can be found in all species and 
evolved over tens of millions of years by high selective pressure1-3. It has roles in protection 
against threats such as viruses, bacteria, parasites, fungi, and foreign or aberrant cells. 
Furthermore, it is involved in repair of damaged tissues and maintenance of integrity1.  
The immune system is always on alert for threats and monitors the body, which collectively 
is referred to as immune surveillance. Although the immune system is a metabolic-costly 
process it is considered the most important determinant for survival and reproductive 
success4. Immune system maintenance and an immune response allocates a significant 
amount of energy resources that could be used for other physiological processes. This is 
illustrated by the trade-off of immune activation in growth impairment in young children with 
low energy reserves, or impaired survival rate of bumblebees under starving conditions5-8. 
Inflammation is the body’s protective response to disturbances in homeostasis such as 
infection, tissue stress and injury. Clinical symptoms of inflammation were first described in 
the first century AD by the Roman scholar Celsus: heat (calor), pain (dolor), redness (rubor), 
and swelling (tumor). Now we understand its purpose is recruitment of immune cells that 
repair the damage and mount an immune response against invading pathogens. 
Inflammatory signals can therefore be viewed as to override or suppress homeostatic controls 
to defend and restore physiological functions when homeostatic mechanisms are failing9. 
Intensity of the immune response needs to be tightly regulated to minimize collateral tissue 
damage. Therefore, the immune response is tightly controlled by positive and negative 
feedback loops that are either cell intrinsic, cell-cell contact dependent, or autocrine- and 
paracrine-mediated10,11. 
The immune system in vertebrates has two main strategies to protect a host from infection: 
an innate and adaptive immune system, which are intimately linked together. Both strategies 
include two functional aspects that work together, namely humoral and cell-mediated 
immunity. Humoral immunity functions via proteins in extracellular fluids and includes 
antibodies, the complement system and anti-microbial peptides, while cell-mediated 
immunity refers to the direct physical interactions of immune cells and foreign adversaries. 
Together, these components of the immune system are able to fight both threats that lure in 
the intracellular (e.g. virus) and extracellular (e.g. bacteria) domain12.  
Genetic inbred strains of mice are a favorable model to study the immune system. The main 
reasons being high reproducibility due to a similar and well characterized genetic make-up 
(identical major histocompatibility complexes (MHC)), and availability of tools and infection 
models. These tools include syngeneic cell transfers without immune responses, and powerful 
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genetic tools to study loss-of-function models and fluorescent tagging of cells and proteins of 
interest. The main mouse strains used in immunology are C57Bl/6 and BALB/c of which their 
immune response is biased towards a Th1 or Th2 response, respectively13. Especially intravital 
imaging of murine immune cells in the last two decades have revealed many of the secrets 
and complexities of the immune system in its native environment, which are otherwise 
impossible to dissect from in vitro cultures or cell aspirations14. Important to realize is that 
mice and humans have evolved in separate paths over 65-75 million years ago which 
inevitably resulted in differences between the immune systems of both, which have to be 
considered when findings in mice are to be translated to humans15. 
1.1.1 Hematopoietic cells of the immune system 
The immune system contains various arms made up by hematopoietic cells that have 
specialized functions and ontogeny. All hematopoietic cells are derived from a hematopoietic 
stem cell that resides in the bone marrow (Figure 1): the adaptive immune system arises from 
the common lymphoid progenitor (CLP), and the innate immune system from the common 
myeloid progenitor (CMP). This is the most basic view of the hematopoietic system as further 
complexity arises beyond this scheme by further classification of subsets and addition of other 
cells, e.g. Dendritic Cells (DCs) and Macrophages (MΦs) come in many different subsets that 
can arise from different progenitors16-18, and T cells contain a high developmental and 
functional diversity19. Furthermore, an Innate Lymphoid Cell Progenitor (ILCP) arises from a 
CLP and gives rise to Innate Lymphoid Cells (ILCs) helper subtypes that do not have antigen 
specific receptors20,21, and can also give rise to Natural Killer (NK) cells22. 
1.1.2 Leukocyte migration 
Function of the immune system relies on the migration of its cells. E.g., it involves the search 
of antigens by DCs in peripheral tissues and migration to lymphatic vessels23, the intranodal 
migration of T cells to find antigen presenting DCs24, and the migration of effector T cells into 
inflamed tissues25. To appreciate the workings of the immune system it is crucial to 
understand how cells are moving around in the body and which signals trigger their attraction 
and retention. Moreover, adaptive immunity relies on the spatial-temporal organization of 
such signals. 
 
Locomotion of cells occurs in two modes, mesenchymal and amoeboid migration, that are 
not necessarily mutually exclusive26. Mesenchymal cells, like fibroblasts and cancer cells, 
migrate in general via the mesenchymal mode, which involves tight adherence to the 
microenvironment via integrins. To move forward protrusions are formed in the direction of 
locomotion. This is followed by formation of new adhesions in the front, subsequent 
deadhesion at the rear and frontwards pulling of the rest of the cell, resembling a caterpillar 
mode of locomotion. 
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Figure 1. Hematopoietic cells of the immune system.  
Image adapted from Janeway’s Immunobiology27. 
 
Leukocytes migrate mainly via the amoeboid mode, which is mostly adhesion-independent. 
The amoeboid mode relies on flowing and squeezing of the cytoskeleton to propel the cell 
forward, and is much faster28,29. Cell guidance is realized by chemoattractants or chemokines, 
small attractant molecules, that create soluble or immobilized gradients in tissues. Using 
receptors that can sense chemoattractants, cells are able to navigate their way into tissues30. 
Complexity arises from a multitude of chemoattractants and receptors that can compete with 
each other, and have distinct effect in various cells types. The complex interactions of cells in 
the lymph node are chemokine-guided and orchestrate the adaptive immune response31 
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1.1.3 Innate immunity 
In its most abstract form, innate immunity entails recognition of bacteria, viruses, protozoa 
and fungi, by recognizing pathogen-associated molecular patterns (PAMPs) 32. Pattern 
recognition receptors (PRRs) on innate immune cells recognize PAMPs and trigger responses 
leading to the elimination of such threats. The innate immune system, especially its 
neutrophils, are crucial for defense against pathogens. Neutropenia, an abnormally low 
concentration of neutrophils in the blood, is associated with high mortality if left untreated. 
Neutrophils are the first line of defense and high numbers of circulating neutrophils are 
required for defense against pathogens that are constantly invading hosts. Without 
neutrophils an individual would not survive more than a few days33.  
The complement system also forms a crucial part of the innate immune system (and humoral 
immunity) and is historically viewed as a supportive first line of defense against microbial 
infections34. It consists of a variety of molecules that act in a cascade by selectively tagging 
intruders, apoptotic cells and cell debris, which enables the subsequent elimination by 
phagocytic immune cells. The cascade is mostly activated on the surface of microbial 
pathogens and leads to the formation of the terminal membrane attack complex, which 
induces cellular disruption and lysis35. In addition complement products bind to surface 
receptors on stromal cells, lymphocytes and myeloid cells, and can initiate inflammation, 
while opsonized antigens potently enhance humoral immunity35.  
The innate immune system also bridges the adaptive immune system via DCs that are 
recruited to the site of infection by the innate immune system. Here, the DCs take up antigens 
for presentation in secondary lymphoid organs (SLO) such as the lymph node or spleen to 
initiate an adaptive immune response36,37. 
1.1.4 Adaptive immunity 
Adaptive immunity is initiated in secondary lymphoid organs, i.e., lymph nodes, white pulps 
of the spleen, and Peyer’s patches, and relies on antigen presentation by antigen presenting 
cells (APCs) to cognate naïve T-and B cells36,38. In contrast to the innate system, the adaptive 
immune system is able to generate selective humoral and cell-mediated attacks to pathogens 
and aberrant cells. T-and B cells are developed such that each cell recognizes only a selective 
antigen39. To prevent lymphocytes from attacking self-antigens, which can result in 
autoimmune pathologies, various tolerance mechanisms are deployed that lead to deletion 
or unresponsiveness of autoreactive cells40,41.  
 
Adaptive immunity is effectively eliminating foreign pathogens by helping cytotoxic T cells kill 
infected cells and B cells to make higher affinity antibodies to protect against extracellular 
pathogens37. Importantly, adaptive immunity also gives rise to memory after a primary 
response, in which a secondary response to the same pathogens can be rapidly initiated to 
provide protection and eliminate a threat before it disseminates systemically42. It is this 
mechanism that is also successfully exploited in vaccination procedures, in which an 
unharmful version of a pathogen is introduced to an individual, allowing the adaptive immune 
system to form memory under safe conditions. This results in protection against real-world 
infection of the vaccine-targeted pathogen43. 
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1.2 Principles of the adaptive Immune response 
Three distinct phases can be distinguished in an immune response: a priming and expansion 
phase, resolution phase, and memory phase43. Antigen presentation by migratory 
conventional dendritic cells to CD4+ helper T cells (Th cells) and CD8+ cytotoxic T cells in 
secondary lymphoid organs initiates the immune response in most cases. The T cell specific 
for the antigen presented by a DC is termed a cognate T cell. Adaptive immune responses are 
complex: depending on the pathogen, APC, antigen availability and communication between 
cells, the type of response, timing, magnitude and memory formation can all be affected44. 
Key events in initiating an adaptive immune response are activation of cognate helper T cells 
by APCs, activation of cognate cytotoxic T cells by the same or different APC, and activation 
of cognate B cells via stromal cells and/or APCs and their further stimulation by helper T cells. 
The paradigm of the T-and B cell response with respect to in vivo spatial-temporal activation 
of T cell subsets and B cells by APCs is still not fully elucidated, but depends on the exact 
circumstances44,45. The key principles regarding antigen presentation, lymphocyte priming, 
tolerance maintenance, and T cell help are discussed below. 
1.2.1 Antigen presentation to T cells  
Antigen presentation by professional APCs to T cells is one of the hallmarks of adaptive 
immunity. APCs constantly patrol tissues and phagocytose encountered antigens. 
Subsequently, an APC processes antigens into small peptides that are loaded onto MHC 
proteins and together form the peptide MHC complex (pMHC). The MHC also plays a crucial 
function in immune surveillance, which involves that all cells present their intracellular milieu 
on their cell surface via pMHC complexes for it to be scanned by patrolling T cells. Protein 
antigen presentation to cognate T cells is restricted to MHC proteins of which the human 
analog is the Human Leukocyte Antigen (HLA) complex. 
1.2.1.1 MHC Restriction and Immune surveillance 
The selective presentation of antigens in context of MHC proteins is referred to as MHC 
restriction, and arises via positive selection of self-MHC-reactive T cells in the thymus and 
ensures that T cells can only be activated under strict circumstances46. MHC molecules come 
in two classes: MHC class I, which are found on all cells and can by recognized by the CD8 T 
cell receptor, and MHC class II which are only found on APCs including DCs, MΦs, and B cells, 
and can be recognized by the CD4 T cell receptor, thereby creating selectivity between CD4+ 
Th cells and CD8+ cytotoxic T cells. Together MHC class I and class II molecules monitor the 
intracellular and extracellular milieu, respectively46. Each cell expresses many MHC class I 
molecules, which can present various peptides that derive from (self or foreign) antigens 
found inside a cell. Patrolling CD8+ T cells monitor the intracellular compartments of these 
cells by scanning pMHC I complexes on cell surfaces. In case of a pathogen infected cell the 
foreign peptide is recognized by the CD8+ T cell as a threat upon which the cell is eliminated. 
In healthy self-cells these peptides are only derived from self-antigens to which CD8+ T cells 
are tolerant.  
 
Additional complexity in antigen presentation arises from the fact that both MHC class I and 
II molecules are polymorphic (composed from different inherited alleles). The number of 
identified alleles for MHC molecules are very large within a population: for MHC I over 10 000 
alleles are identified. For MHC class I and II proteins, 3-6 and 3-12 variants can be available to 
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an individual, respectively. This variety of MHC molecules results in variation in the MHC-
peptide binding groove with the effect that different fragments of an antigen are presented 
via different polymorphic MHC molecules, which allows for expression of a greater number 
of different peptides. MHC polymorphism is also the reason for transplant rejection and 
certain autoimmune reactions are correlated with specific MHC polymorphs46. 
1.2.1.2 T cell priming 
Soluble antigens, bacteria and other pathogens can be taken up by professional APCs via 
phagocytosis, endocytosis and macropinocytosis. These antigens are subsequently internally 
digested and processed into peptides for presentation to CD4+ Th cells via MHC class II 
molecules, and it is this process that initiates an immune response in vivo36,46. DCs and MΦs 
also present exogenous antigens via MHC class I directly to CD8+ T cells in a process called 
cross-presentation. This leads to the clonal expansion of these cognate T cells that are 
eventually released into the periphery to eliminate the infectious threat. Different subsets of 
DCs have been shown to be more efficient, but not restricted, in either presentation via MHC 
class I or MHC class II, of which the underlying mechanisms for this specificity is still a matter 
of debate47. It is estimated that a given average antigen can only be recognized by 1 in 105-
106 T cells48,49. 
1.2.1.3 Antigen presentation: Immune response or Tolerance? 
Upon capture, phagocytosis and digestion of a pathogen in peripheral tissues, DCs migrate to 
the draining lymph node where they present antigens via MHC class II to CD4+ Th cells, which 
leads to the initiation of an immune response or establishment of peripheral tolerance36. 
These two different outcomes depend among others on the maturation state of the DC and 
the strength of antigen presentation, and is partly decided at the moment of antigen uptake50. 
When phagocytosing a pathogen, additional danger signals are received by the DC via toll-like 
receptors (TLR), cytokine receptors such as Tumor Necrosis Factor (TNF) receptors, Fragment 
crystallizable Receptor (FcR), and sensors for cell death. This drives the DC into a 
developmental program termed maturation which enhances its potency of antigen 
presentation and upregulates co-stimulatory molecules and chemokine receptors that 
facilitate efficient migration to the draining lymph node and ensures potent stimulation of 
CD4+ Th cells50,51. T cell priming by an APC results in maturation of cognate naïve CD4+ and 
CD8+ T cells into functional T helper cells and CD8+ effector cells, respectively. This 
stimulation consists of three signals: 1) APC-MHC complex to the T cell Receptor (TCR) and 2) 
APC co-stimulatory molecules (such as CD28) to T cell ligands (such as CD80 and CD86), and 
3) soluble cytokines52. When both TCR and co-stimulation are received, CD4+ and CD8+ T cells 
clonally expand in great numbers within SLOs, that are needed to induce a strong immune 
response.  
 
When danger signals are missing in the case of uptake of a self-antigen, DCs remain immature 
and are less efficient in homing to the draining lymph node, resulting in weaker stimulation 
of CD4+ Th cells50. Missing co-stimulation triggers anergy in T cells, and is one of the 
mechanisms of how peripheral tolerance to antigens is induced50,52. Self-antigen presentation 
by migration of immature DCs to the draining lymph node is constantly happening in steady-
state conditions, and therefore maintenance of peripheral T cell tolerance by DCs is an active 
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process51. Induction of tolerance, like initiation of an immune response, can occur via 
presentation via MHC class II or cross-presentation via MHC class I53. 
1.2.2 Antigen Presentation to B cells 
B cells can only recognize their cognate antigen in its undigested native form via their B cell 
receptor (BCR) both in soluble, but more effectively, in membrane-bound form54. The antigen 
can be presented to cognate naïve B cells in various ways that involve either lymph node 
resident MΦs and DCs taking up soluble antigens arriving via the lymph or blood, or via 
follicular dendritic cells (FDCs), a specialized stromal cell type that can present native antigens 
for months. The latter one involves non-cognate B cells to transfer opsonized soluble antigens 
(proteins, sugars, and lipids) to FDCs: soluble antigens can be captured by non-cognate B cells 
directly, or indirectly via resident MΦs and DCs that subsequently transfer it to a non-cognate 
B cell for transfer onto FDCs54. 
1.2.2.1 B cell priming, fate and function 
 
The BCR is the membrane-bound form of the antibody a B cell produces and is specific for an 
antigen. Upon cognate antigen engagement and interaction with Th to receive additional 
signals, B cells proliferate and can undergo different fates. Initially, primed B cells will increase 
in numbers, differentiate and start secreting antibodies against their cognate antigen40. 
Depending on the received signals, activated cognate B cells can become plasma cells, which 
quickly secrete specific low-affinity antibodies, or form a germinal center (GC) where antibody 
affinity maturation takes place. To produce higher affinity antibodies, B cells need help of 
follicular helper T cells (Tfh) and stromal cells within GC, upon which B cells undergo somatic 
hypermutation (SHM) and affinity maturation in germinal centers. The latter process requires 
continuous antigen presentation and selection of randomly mutated BCRs. Affinity matured 
B cells can subsequently become plasmablasts (immature plasma cells which secrete 
antibodies and can divide rapidly), may enter GC for additional rounds of SHM and affinity-
maturation, or become memory cells54. Plasmablasts can stay in an immature state for several 
days after which they either die or mature into plasma cells. Plasma cells secrete high 
numbers of antibodies that distribute via lymph and blood to all peripheral tissues in order to 
attach to their cognate antigens, thereby guiding both the innate and adaptive immune cells 
to eliminate the threat55. 
1.2.2.2 B cell Tolerance 
As a result of development, more autoreactive cells exist within the B cell than the T cell 
repertoire. Their frequency is reduced via several mechanisms at different stages of B cell 
development. Autoreactive B cells are deleted by apoptosis in the bone marrow after being 
exposed to abundant self-antigens. Further, in the early development phase, central 
tolerance results from a process of receptor editing in which autoreactive B cells in the bone 
marrow edit their immunoglobulin M (IgM) receptor by Ig gene recombination that modifies 
their specificity and enhances immune diversity, thereby uncoupling BCR specificity and cell 
fate40. Together these central tolerance mechanisms are able to remove 90% of autoreactive 
B cells from the periphery. Peripheral tolerance is required to remove the last proportion of 
autoreactive B cells and depends on the interplay of BCR-mediated signals and the B cells 
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survival factor, B cell activating factor (BAFF) signaling56. Peripheral tolerance includes 
removal of autoreactive B cells during GC processes. 
1.2.3 T cell Help 
T cell help is crucial for efficient primary B cell and CD8+ T cell immune responses. Depending 
on the stimuli CD4+ Th cells differentiate into different phenotypes that polarize the immune 
response to adapt to the invading pathogen. T cell help is involved in the priming, resolution 
and memory phase of the immune response and aids in B cell antibody formation, induction 
of microbicidal activity in MΦs, recruitment of innate immune cells to sites of infection, 
secretion cytokines and chemokines that orchestrate the immune response, and are 
implicated in B cell CD8+ T cell memory formation57,58.  
1.2.3.1 Th subsets and polarization of the immune response 
Conventional CD4+ Th cells are activated upon successful APC engagement. At least five 
distinct fates are distinguished: Th1, Th2, Th17, Tfh, and induced regulatory T cell (iTreg). 
These Th subsets differ from each other in cytokine production and in effector function, 
thereby effectively polarizing the immune response by orchestrating which cells are involved 
and what type of response is invoked57,59. Th1 cells orchestrate responses against intracellular 
pathogens, Th2 cells are important in mediating responses against extracellular parasites, 
Th17 cells mediate host defenses against extracellular bacteria and fungi, and Tfh cells are 
involved in germinal center antibody maturation. Regulatory T cells (Treg) cells are critical in 
maintaining self-tolerance, and play an important role in regulating immune responses by 
dampening T cell activation and activity. Which Th subset is involved in the immune response 
is pathogen dependent and can be traced back to the activation of APCs. Activation of distinct 
receptors on DCs by different pathogens and antigens invoke secretion of distinct cytokine 
profiles, that via positive and negative feedback mechanisms induce the differentiation of 
naïve CD4+ T cells to one of the various Th subsets. For inducible Treg differentiation, the 
signaling of TGF-β in the absence of pro-inflammatory signals is the main driver57. 
1.2.3.2 T cell help in the cytotoxic T cell response 
Immune responses can be mounted both with and without CD4+ T cell help, but the absence 
can have detrimental effects on the magnitude of the cytotoxic response60. In the priming 
phase, DCs interacting with cognate CD4+ T cells will also subsequently prime cognate CD8+ 
T cells. The helper T cells will give an additional CD40 signal to the DCs, which invokes further 
maturation of the DCs, which in turn enhances CD8+ priming functions. This is referred to as 
DC licensing, and its enhancements include secretion of chemokines that attract naïve CD8+ 
T cells, and secretion of pro-survival cytokines that support long-term (memory) survival of 
CD8+ T cells. Activation of CD8+ T cells that yield an effective primary immune response can 
happen in absence of Th cell activation but fails to produce long lasting memory CD8+ T cells, 
and results in a weak secondary immune response upon re-stimulation by the same antigen58. 
Licensed DC help is also exerted via CD70 on the DCs, and CD27 on CD8+ T cells, and results 
in improved peripheral tissue invasion potential and downregulation of co-inhibitory 
molecules, and thereby enhances their effector functions upon viral infection or 
immunization60. 
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1.2.3.3 T cell help in in the humoral response 
Help in the humoral response is mediated via Tfh cells. Upon differentiation by APC 
engagement, effector Tfh cells upregulate the C-X-C Motif Chemokine Receptor 5 (CXCR5) and 
migrate towards B cell follicles, where help is given in three phases59. First, B cells expand in 
numbers with the help of Tfh outside the follicle and form plasma cells. Second, Tfh B cell 
interactions in the follicle lead to the clustering of B cells on FDCs and the subsequent 
formation of a germinal center. In the third GC reaction phase, Tfh cells are involved in 
selection of GC B cells that undergo SHM and antibody affinity maturation.  
 
In the extrafollicular phase, CD40L upregulation on Tfh cells provide the long-lived contact 
signals for initial plasma cell production. Inside the GC, interactions are shorter. The GC 
consists of a dark and light zone. Selection takes place in the light zone, where FDCs and Tfh 
cells reside. Tfh cells select high-affinity B cells and drive the cyclic evolution of antibody 
affinity maturation after which Tfh cells export cells from the GC as either memory or plasma 
cells to carry out its effector functions in the humoral response59,61. The Tfh cell-mediated 
selection of B cells in the light zone of the GC depends on antibody affinity. Contact times 
between both cells are mediated via an intracellular feedback mechanism. Proportional 
longer Tfh cell-B cell interactions in the light zone is occurring when affinity is high, and results 
in proportional more division of B cells in the dark zone before further rounds of SMH and 
antibody maturation. This contact time-mediated proliferation capacity thereby enlarges the 
contribution of the plasma and memory cells with higher affinity. Tfh also possess the ability 
to migrate between follicles and form long-lived memory cells59,61. 
1.3 Lymphoid Organs 
A functional immune system relies on checks and balances that depend on the timely 
interaction between various immune cells11,62. Lymphoid organs provide these needs by 
spatially organizing various cell types, thereby both limiting and promoting specific 
interactions between the immune cells that keep the immune system in check. This entails 
immune cells not to attack self-antigens (e.g., proteins derived from self-cells, or food intake), 
while at the same time streamline cellular interactions to rapidly mount an immune response 
to real threats. Therefore, lymphoid organs can be viewed as strategically distributed hubs 
throughout the body that support the interactions of immune cells and their specific 
immunological functions. Lymphoid organs can be further distinguished in primary, secondary 
and tertiary structures, defining and separating specific locations where new immune cells 
are formed (antigen-independent) and adaptive immunity is initiated (antigen-dependent) 63. 
Furthermore these organs differ in their immune cell entry and exit points and their 
development is either site and time specific, and does not require inflammatory stimuli 
(primary and secondary structures), or are developed in result to stimuli (some secondary, 
and all tertiary lymphoid structures). All lymphoid tissues are made up of a mixture of stromal 
cells, myeloid cells and lymphocytes in which specialized niches support various components 
of the immune system. The roles of the different lymphoid organ types are further discussed 
below. 
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1.3.1 Primary lymphoid organs 
Primary lymphoid organs (PLO) comprise the bone marrow and thymus. The main function of 
the bone marrow is hematopoiesis: the generation of the various lymphoid and myeloid cell 
types. Hematopoietic stem cells give rise to all blood cells and are able to self-renew, while 
differentiated, lineage-committed progenitor cells have a limited capacity to self-renew and 
live in the order of weeks. An average individual produces about 500 billion hematopoietic 
cells per day64. Therefore, tight regulation of self-renewal and differentiation is necessary to 
ensure homeostasis, since failures of these mechanisms could lead to pathologies such as 
leukemia65.  
The thymus produces mature T cells by selection of thymocytes (immature T cells) and thus 
maintains central tolerance. Thymocytes are given survival signals if they recognize self-MHC 
and if they do not react to self-antigens, including peripheral tissue antigens. Thymocytes  
enter the thymus from the blood where they follow chemokine gradients produced by 
stromal cells (thymic endothelial cell (TEC) populations) to guide their maturation in distinct 
steps at distinct micro-anatomical locations66. After selection, the now trained T cells exit the 
thymus either mainly via the blood, and less efficiently via efferent lymphatic vessels63.  
1.3.2 Secondary lymphoid organs 
SLOs are the meeting place of immune cells and are crucial for the initiation of immune 
responses. SLO include lymph nodes, splenic white pulp, Peyer’s patches, tonsils and mucosa-
associated lymphoid tissues (MALTs). MALTs include lymphoid tissues surrounding the 
respiratory tract (Bronchus-associated lymphoid tissue (BALT)), intestinal tract (Gut-
associated lymphoid tissue (GALT)) and nose cavity (Nasal-associated lymphoid tissue 
(NALT)). While lymph nodes, spleen and Peyer’s patches are formed during embryonic 
development, formation of other structures like MALTs and tonsils is age and/or stimuli-
dependent63. 
Lymph nodes are involved in surveillance of skin, mucosa and virtual all tissues by draining 
lymph. MALTs surveil mucosal barriers, Peyer’s patches obtain antigens by epithelial 
transport from the intestinal lumen, and the spleen is filtering blood-borne pathogens and 
antigens and regulates iron metabolism and erythrocyte homeostasis67-69. Together SLO 
ensure the constant filtering of lymph, blood, and mucosal barriers and initiate immune 
responses or promote tolerance. Differences of entry and exit routes between SLOs exist. 
While immune cells enter and leave the spleen via the blood, immune cells can enter lymph 
nodes both via the lymph and the blood, but exit via efferent lymphatic vessels. Furthermore, 
specific post-capillary venules with high endothelium (High endothelial venules or HEVs) can 
be found in lymph nodes, Peyer’s patches, tonsils and BALT, and facilitate the entry of 
immune cells. HEVs are not found in the spleen where immune cells enter via arteries or 
venous sinuses63. HEVs can have distinct adhesion molecules to differentially recruit specific 
subsets of immune cells into gut-associated SLO versus peripheral SLO, and this HEV 
patterning is determined postnatally by the gut microbiome and migrating DCs70. 
To mount an immune response, antigen bearing DCs and naïve T cells have to initially interact. 
This entails that DCs have to find rare cognate T cells by chance, which in a large organism 
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that consists of trillions of cells is astronomically rare. Secondary Lymphoid organs are the 
answer to this problem as they organize the immune response by functioning as rendezvous  
points for immune cells71. It is here that antigen bearing DCs migrate to from the periphery, 
and naïve lymphocytes adopt a random migration strategy to optimize the number of 
interactions with antigen presenting DCs. It is estimated that a T cell can interact with 
hundreds of different DCs per hour, while a given DC is estimated to interact with 2000 
different T cells per hour24,72. This successful strategy overcomes the unlikelihood of naïve T 
cells interacting with its cognate antigen bearing DCs. Furthermore, SLO streamline the 
availability of antigens to APCs and B cells within the organ to optimally initiate cellular and 
humoral immune responses54.  
Once a foreign antigen is encountered and presented, draining lymph nodes swells and rapid 
changes take place in these organs to facilitate immune responses. The swollen lymph node 
is also referred to as the reactive lymph node, and is discussed in more detail in chapter 2. 
1.3.3 Tertiary lymphoid organs 
Tertiary lymphoid organs or structures (TLSs) develop do novo in the adult organism in the 
context of chronic inflammation, auto-immunity and cancer. They are ectopic hubs that 
resemble SLOs and aid in adaptive immunity73. In contrast to SLOs, TLSs develop via a different 
mechanism that involve the activation of postnatal and locally derived fibroblasts instead of 
the embryonic-derived lymphoid stromal progenitors found in PLOs and SLOs. It has been 
demonstrated that FDCs, normally found in SLOs, can be derived from perivascular cells in 
TLSs74. In addition to differential developmental mechanisms, anatomical differences 
between TLSs and SLOs persist. TLSs do not contain afferent lymphatics, however can form 
efferent lymphatics to facilitate egress of lymphocytes. Both entry and exit of lymphocytes  
can be further supported via formed HEVs. 
TLSs can be physiological, e.g., in context of long-term stimulation by microbial factors, that 
lead to TLSs in the gut63. However, TLSs are not always beneficial: although they can aid in 
local dampening of an immune response, in some situations undesirably chronic 
inflammation is promoted. Such is the case in some auto-immune diseases, e.g., multiple 
sclerosis and rheumatoid arthritis75-77. 
1.4 The Lymph Node 
Lymph nodes are part of the lymphatic system and are found only in mammals where they 
are strategically distributed throughout the body and connected to each other in chains via 
lymphatic vessels78. Their main functions are (1) draining and filtering of interstitial fluid and 
shunting it back into the blood circulation, and (2) initiating adaptive immune responses and 
maintaining peripheral tolerance. Lymph is the name for concentrated Interstitial fluid once 
entered in the lymphatic vessel. From here, the lymph is drained via afferent lymphatic 
vessels towards the lymph node where it is filtered and (1) shunted to venous blood vessels 
within the organ, and (2) transported via efferent lymphatic vessel to the next lymph node in 
the chain. Eventually, the lymph drains into a collective lymphatic duct that empties in the 
venous blood circulation at the site of the subclavian vein. To aid in the initiation of adaptive 
immunity, lymph arriving via afferent lymphatics is constantly sampled in the lymph node by 
tissue resident MΦs and DCs that can rapidly present captured antigens to T cells79,80. 
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Lymph nodes are localized in such a way that that they drain interstitial fluid of a single 
anatomical region. While in the mouse often a single lymph node is found per draining region, 
in humans, lymph nodes come in clusters, and it has been estimated that humans have 
between 500-700 nodes. In general, lymph nodes can be distinguished based on their draining 
region in either skin or mucosal-draining lymph nodes. The mesenteric lymph node is a unique 
case as it drains fluids from the digestive tract, and has the special function of organizing 
tolerance to foreign digestive food products and a commensal microbiota, while initiating an 
immune response against harmful pathogens81,82. Filtration and distribution of lymph within 
the lymph node is determining which soluble information is delivered at microanatomical 
locations within the node, and is important for shaping the adaptive immune response83.  
 
Lymph nodes come in different shapes and sizes. While murine popliteal lymph nodes, found 
embedded in the adipose tissue of the popliteal fossa, are spherical in shape and about 1 mm 
in diameter, inguinal lymph nodes, found in the femoral triangle, are bean-shaped and 
roughly double the size with a length of about 2mm. In humans, inguinal lymph nodes are 
oval shaped with a diameter of around 0.5cm, and come in groups of 4-2084. Human popliteal 
lymph nodes are found as a single oval-spherical node that is around 0.7cm in diameter85. 
 
1.4.1 Organization of the lymph node 
Leukocytes are the main cell type found in the lymph node (around 98%), while the rest is 
made up of mesenchymal stromal cells. Historically, it was believed that these stromal cells 
were only involved in forming the scaffold for lymphoid organs. However, in the last decade 
many immunological roles for stromal cells were discovered, and it is now understood that 
immunity fails without a functional stromal network. This is evident from studies showing a 
complete abrogation of the immune response in infections that affect lymphoid stromal cell 
viability, and in genetic mouse models where stromal cells are selectively ablated 86-89. It is 
the stromal cell populations that organize immune responses and compartmentalize the 
lymphoid organs in functional niches by secreting distinct chemokines, form extracellular 
matrix structures, and support function and survival of immune cells. 
 
I will continue by first discussing the anatomy of murine and human lymph nodes, and the 
main stromal and lymphoid cell types that can be found in these organs. Extra emphasis will 
be put on stromal cells and their role in homeostasis and adaptive immunity.  
1.4.2 Stromal cells and functional compartments in the lymph node 
Lymph nodes are highly compartmentalized organs (Figure 2). In the homeostatic lymph node 
four areas can be distinguished: a medulla at the hilar region, a central paracortex, peripheral 
B cell follicles, and cortical ridge/inter-follicular cortex (IF) regions. The whole organ is 
encapsulated by a subcapsular sinus (SCS) space to which the afferent and efferent lymphatic 
vessels connect and shunt the lymph around the organ. The whole organ is further 
encapsulated by a fibrous and elastic capsule. Stromal cells form these distinct anatomical 
regions and maintain specific functions of those compartments by regulating the migration, 
retention and differentiation of immune cell populations. Such is the case for the segregation 
of B cells and T cells in follicles and the paracortex (T zone), respectively90,91. Human lymph 
nodes have the same compartments found in murine lymph nodes, however, they are made 
 13 
up of functional lymphoid lobules. Lobules are the functional units and each lobule contains 
all of the compartments: follicles, medulla, IF regions, and T zone. Individual lobules are 
segregated by transverse lymphatic sinuses. The cortical lymphatic sinuses protrude into the 
cortex from the SCS. Small lymph nodes may have a single or few lobules, while large ones 
contain many92. 
 
The main stromal cell types in lymphoid organs can be distinguished by the expression of two 
surface receptor: Podoplanin (PDPN), a small mucin type receptor, and Platelet endothelial 
cell adhesion molecule (PECAM-1 or CD31) 93,94. Lymphatic Endothelial Cells (LECs) are 
PDPN+CD31+, while blood endothelial cells are PDPN-CD31+. A small group of double 
negative population PDPN-CD31- have been identified as perivascular cells, while the majority 
of the stromal cells are PDPN+CD31- Fibroblastic Reticular Cells (FRCs). FRCs produce almost 
all extracellular matrix which together forms the backbone of the organ. FRCs form a reticular 
three-dimensional (3D) topological small-world cellular network which follows a matrix 
network composed of fibrillar collagen, microfibrillar- and basement membrane components  
that they themselves enwrap and contract80,89,95. Together the FRC extracellular matrix 
components form lymph-transporting acellular vessels called conduits. FRCs are a 
heterogenous group of cells. Single cell Ribonucleic acid (RNA) sequencing recently identified 




Figure 2. Functional compartments in the murine lymph node.  
Image adapted from Mueller et al. 90. 
 
1.4.2.1 Immune functions of Stromal cells 
Stromal cells organize the lymph node in functional compartments by secretion of distinct 
chemokines thereby regulating migration, retention and thereby interactions between 
immune cells 90,97. Furthermore stromal cells secrete survival factors for immune cells and 
dictate the number of immune cells that can be sustained at a given moment 88,93. Besides 
their roles in structural support and formation of immunological compartments within SLOs, 
stromal cells have been shown to be directly involved in immune functions98,99. FRCs are 
shown to negatively regulate immune responses by directly cross-presenting peripheral 
antigens to promote peripheral tolerance of self-reactive CD8+ T cells100. In addition, low 
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expression of MHC class II by FRCs and transfer of MHC class II from DCs to FRCs is involved 
in delaying cognate T cell proliferation upon re-stimulation94,101. Furthermore FRCs can sense 
interferon-gamma (IFN-ɣ) produced by activated T cells ,and in turn transiently produce nitric 
oxide gas and prostaglandin E2, which dampens T cell proliferation102-105. Functionally, FRCs 
are proposed to thereby limit the excessive expansion and function of antigen specific T 
cells106. 
1.4.2.2 Subcapsular Sinus 
The subcapsular sinus is a 3D enclosed space that surrounds the lymph node parenchyma and 
is lined by LECs. The LECs of the ceiling (cLEC) and floor (fLEC) are distinct populations that 
cooperate together to facilitate the entry of DCs and T cells arriving via the lymph such to 
enter the underlying parenchyma. This entry relies on the chemokine receptor CCR7 
expression on immune cells107,108. fLECs secrete the CCR7 ligand homeostatic chemokine C-C 
motif ligand 21 (CCL21) while cLEC express the atypical chemokine C-C motif receptor ligand 
1 (CCRL1) that scavenges this chemokine, thereby effectively creating a soluble gradient 
directed towards the floor that promotes migration from the SCS into the underlying 
parenchyma. T cells arriving via the lymph mainly enter the parenchyma via cortical and 
medullary sinuses, while DCs migrate through the SCS, creating hotspots where T cells can 
follow these cells. 
The extracellular matrix network extends from the parenchyma through the SCS where it 
attaches to the capsule and is enwrapped by strand LECs (sLECs). sLECs express the 
glycoprotein Plasmalemma Vesicle Associated Protein (PLVAP) that acts as a molecular sieve 
and sterically hinders entry into conduits of molecules larger than 70kDa, from which it can 
be transported into underlying parenchyma (Figure 3) 109.  
 
 
Figure 3. Distribution of small and large soluble molecules at the SCS.  
Image adapted from Hons et al. 110. 
 
The SCS is also home to a distinct CD169+ MΦ population that resides just under the SCS. 
These MΦs monitor the SCS space for large soluble antigens that they can take up and present 
to B cells and natural killer T cells (NKT cells) 111,112. Furthermore, a population of DCs that 
reside in the SCS have been identified that can induce rapid immune responses to lymph 
borne particulate antigens113. Together, phagocyting immune cells and the molecular sieves 
of the SCS form the filter function of the lymph node. 
 
The formation and maintenance of the MΦ niche is complicated and relies on signaling via 
both stromal cells and immune cells. Proper differentiation of SCS MΦs relies on Receptor 
activator of nuclear factor kappa-β ligand (RANKL) stimulation via Marginal Reticular Cells 
(MRCs), a mesenchymal stromal population that is found adjacent to the fLECs and SCS 
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MΦs114. The SCS MΦ niche is further maintained by secretion of Colony Stimulating Factor 1 
(CSF-1) by LECs115. In functional terms, B cell-derived lymphotoxin α1β2 (LT) cell surface 
complex signaling is necessary for rendering SCS MΦs permissive for vesicular stomatitis 
virus, an essential step for producing type I IFN production to prevent fatal invasion of 
intranodal nerves116.  
 
1.4.2.3 Paracortex and Interfollicular regions 
The paracortex is formed by T zone Reticular Cells (TRCs), a subset of FRCs, and consists of a 
dense sponge-like conduit network. TRCs produce homeostatic chemokines Chemokine C-C 
motif ligand 19 (CCL19) and CCL21 that attract and retain T cells and DCs that are both 
migrating on this FRC network93,117,118. T cells utilize the TRC network as highways. 
Intercellular adhesion molecule (ICAM) and vascular adhesion molecule (VCAM) ligands 
expressed on TRC surfaces, together with secreted homeostatic chemokines, guide the 
intranodal migration of T cells29,119,120. Furthermore, TRC-expressed cytokine interleukin 7 (IL-
7) supports the survival of naïve T cells by forming a niche in which these cells compete for 
survival93. It is estimated that conduits are 90% covered by TRCs and that the other 10% is 
covered by MΦs, DCs and lymphocytes121. APCs at the interface of the conduit extracellular 
matrix are able to take up small soluble antigens that passed the filter at the SCS and drain 
into the paracortex79,80. The T zone is also home to a population of CX3C chemokine receptor 
1 (CX3CR1), and proto-oncogene tyrosine-protein kinase MER (MERTK) expressing resident 
MΦs that eliminate apoptotic cells122.  
 
HEVs are preferentially found at the peripheral sites of the paracortex, and these post-
capillary venules are the main entry point for lymphocytes and blood-derived DCs. Luminal 
expression of selectins, peripheral node addressin (PNAd), glycoprotein bound CCL21, C-X-C 
Motif Chemokine Ligand 12 (CXCL12), and ICAM on these endothelial cells provide the 
necessary molecular cues to support lymphocyte diapedesis123. Entering lymphocytes have to 
first pass through a layer of endothelial cells that form pockets for lymphocytes, and 
subsequently a perivascular sheet before the parenchyma can be accessed. It is believed that 
these pockets are waiting areas for lymphocytes, and that HEVs are able to control lymph 
node cellularity under homeostatic conditions124. Naïve lymphocytes enter lymph nodes 
preferentially via HEVs, but can also access the parenchyma via cortical and medullary 
sinuses, such can be the case for memory T cells recirculating from peripheral tissues, or naïve 
and recirculating memory T cells arriving via afferent lymphatics originating from the previous 
lymph node in the chain107,125. 
 
The IF regions are found in between the follicles and contain a similar, albeit denser conduit 
network formed by TRCs. These regions have a high density of MΦs, DCs and innate that allow 
efficient communication between these cells, which have important roles in initiation 
immune responses against lymph borne pathogens44,112,126,127. 
 
Localization of migratory and tissue resident conventional DCs (cDCs) is governed by stromal 
cells and has implications in shaping of the immune response. Migratory DCs pass through 
the IF regions and migrate to the paracortex in a CCR7 dependent manner, where also the 
cDC1 population resides83,128. In contrast, cDC2 have lower expression of CCR7 and express 
higher levels of Epstein-Barr virus-induced G- protein coupled receptor 2 (EBI2), the receptor 
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for the oxysterol chemokine, which is essential for their localization in IF regions and the outer 
paracortex83,129. 
1.4.2.4 Medulla 
The medulla is found extending from the hilar region of the lymph node where the blood 
vasculature and efferent lymphatic vessel are entering the organ. This region serves some 
well-defined functions that include monitoring and clearing of antigens and pathogens, 
providing exit routes for lymphocytes and locally secreted antibodies, and supporting survival 
of plasma cells. Lymph drained from afferent lymphatics will fill the irregularly structured 
medullary sinuses that extent from the SCS before it is drained into the efferent lymphatic 
vessel. MΦs and DCs residing at medullary lymphatic vessel walls have therefore strategic 
access to lymph born antigens and pathogens130,131. The parenchyma between the lymphatic 
vessels are termed medullary cords, and contain a reticular network formed by FRCs and 
often contains a central blood vessel. These spaces are mainly filled with plasma cells and 
their precursors, lymphocytes, MΦs and DCs132. 
 
The medulla plays an important role in facilitating the egress of lymphocytes133. LECs of the 
medulla produce the lysophospholipid chemoattractant Spingosine-1-Phosphatase (S1P) that 
attracts lymphocytes expressing the Spingosine-1-Phosphatase receptor 1 (S1PR1). S1P 
concentrations are high in the lymph and blood, but low in lymphoid organs. Therefore, this 
chemoattractant facilitates the migration of lymphocytes from the lymphoid compartment to 
the medullary sinuses and subsequent efferent lymphatics that eventually drains into the 
blood circulation, restarting a new round of recirculation. It is unclear what mechanism 
determines the time a lymphocyte resides within the lymph node. Since S1PR1 engagement 
with its ligand triggers internalization, re-sensitization to S1P after a given time within a SLO 
could be an explanation133. 
 
Medullary cords form important niches for plasma cells. B cells that migrate here directly after 
T cell encounter at the T-B zoned boundary differentiate into short-lived plasma cells 
secreting lower-affinity antibodies thereby limiting systemic pathogen spread early during an 
infection. Plasma cell homeostasis in medullary cords is maintained by a defined FRC 
population, termed Medulary Reticular Cells (MedRCs), that form supportive niches134. 
MedRCs are MadCAM-CD157- FRCs and secrete IL-6 and CXCL12 necessary for plasma cell 
differentiation and survival, and plasma cell attraction, respectively. An additional FRC 
population has been identified that resides in the FRC cortex medulla boundary135. 
 
1.4.2.5 B cell Follicles 
B cell follicles are preferentially found at peripheral sites of the lymph node parenchyma, and 
are dense foci of B cells and various stromal cells, containing only little extracellular matrix. 
These structures are critical in humoral immunity and are responsible for the generation of 
high-affinity antibodies and the formation of memory B cells, providing the second wave of 
humoral response including protections against reinfection by the same or similar pathogen. 
FDCs are the main stromal cells within the follicle where they are localized in the center and 
secrete the C-X-C Motif Chemokine Ligand 13 (CXCL13) chemoattractant, BAFF and IL-6 to 
attract, retain and support B cells35,88,136,137. FDCs are critical in formation of germinal centers 
(GCs) that drive the high-affinity antibody formation and B cell selection following infection 
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or immunization. GCs are formed by two compartments: a dark zone where B cells first 
undergo proliferation and hypermutation, and a light zone where B cells subsequently 
undergo antigen-driven selection by FDCs and Tfh cells. This process can be repeated to 
further drive antibody affinity maturation, or B cells can exit the GC to become long-lived 
plasma cells or memory B cells138. Using their CD21/CD35 complement receptors, FDCs are 
able to take up and retain opsonized antigens and IgG antibodies for long periods of time 
(estimated up to ten years). Long term storage is crucial for maintenance of the GC and high 
affinity antibody maturation and FDCs constantly recycle to the cell surface antigens stored 
within the cell136. During immune responses, lymph node FDCs can derive at least in part from 
a mucosal vascular addressin cell adhesion molecule 1 (MadCAM-1) positive MRC population 
that resides directly under the SCS139. Besides FDCs, other fibroblastic stromal cell types can 
be found in the outer area of follicles, that are termed B zone Reticular Cells (BRCs) and 
Versatile Stromal Cells (VSCs). Collectively these cells produce CXCL13, BAFF, the 
chemoattractant oxysterol, Notch-ligand delta-like 4 (DL4), and are involved in B cell 
attraction and survival, attraction of primed Th cells, differentiation of Tfh cells, expanding 
the B cell follicle into the paracortex in reactive lymph nodes, and segregating different areas 
in GC responses88,140-143.  
 
1.4.3 Development and maintenance of lymph nodes 
Formation of lymph nodes in mice kept under pathogen-free conditions leads to the robust 
formation of 22 lymph nodes in distinct locations144. Conversely, in humans there is a high 
variability in the abundance of lymph node formation, as is illustrated in the neck region 145 
Since ectopic lymph nodes are also found in pathological situations, it was suggested that the 
formation of lymph nodes is an adaptive process146,147. Development of murine peripheral 
lymph nodes start between embryonic day 14-16 and continues postnatally148. The two-cell 
model is the currently the most accepted explanation of the sequence of events leading to 
the development of these organs, and involves the interaction between hematopoietic origin 
Lymphoid Tissue Inducer (LTi) cells and mesenchymal Lymphoid Tissue Organizer (LTo) 
cells149. Recently it has been shown that besides LTo’s, LECs also have an important role in 
initiation of most lymph node anlagen, the critical structure from which the organ 
develops150. It is now believed that first Receptor activator of nuclear factor k-β (RANK) 
receptor-mediated interactions between LECs and LTi’s, which recirculate in neonatal 
peripheral tissues, drive the initial activation of LECs, that in turn result in the recruitment of 
a critical number of LTi’s. This process depends on sensing of chemokines via CCR7 and 
CXCR5148. RANK stimulation of LTi’s by LECs results in the surface expression of LT on LTi’s. 
The subsequent interaction between LTi derived LT and the respective LTo surface receptor 
Lymphotoxin beta receptor (LTβR) eventually gives rise to the various lymphoid stromal cell 
populations, while interactions with blood endothelial LTo’s result in the formation of HEVs 
that attract lymphocytes148. Both RANK and LTβR signaling activate NF-kβ via the canonical 
and non-canonical pathway, and are crucial as knockout mice do not develop any lymph 
nodes151,152. LTβR is a crucial signaling receptor in the formation and maintenance of 
lymphoid stromal compartments and can be found on all stromal cells, while its membrane-
bound ligands LT and LIGHT (‘homologous to lymphotoxin, exhibits inducible expression and 
competes with HSV glycoprotein D for binding to herpesvirus entry mediator, a receptor 
expressed on T lymphocytes‘) are found on various immune cells148,153. Many stromal cells are 
highly plastic and constantly rely upon signaling via LTβR to maintain their phenotype and 
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function. Blockage of the pathway by antagonistic LTβR-Ig, a soluble form of the receptor, 
results in the collapse and disorganization of FDC and splenic TRC stromal networks, while 
other network such as lymph node TRCs are much less sensitive153,154. The formation and 
maintenance of the T zone, HEVs and B cell follicles are further discussed below. 
1.4.3.1 Formation and maintenance of the T cell Zone 
Examples of developmental processes involving LTβR signaling have been described for FRCs. 
FRCs in vitro rely on T cell derived LT and TNF-α to produce extracellular matrix proteins155. 
Conditional ablation of the LTβR in FRCs surprisingly still results in the formation of an FRC 
network. However, FRCs were locked in an immature myofibroblastic state lacking expression 
of chemokines and adhesion molecules, and mice were shown to be immune incompetent156. 
In the spleen, B cells and T cells have been shown to promote LTβR on FRCs and stimulation 
in the production of homeostatic chemokines157-159. A role for T cells in balancing the 
expansion of the medulla and T zone has also been described: T cell-derived IFN-ɣ negatively 
impacts the expansion of lymphatic vessels and possibly allows the further expansion of the 
T zone160. A possible role for RANK in the control of organ size has been postulated. 
Overexpression of RANKL in hair follicles that drain the ligand to peripheral lymph nodes 
resulted in massive growth of these organs161. Although LTβR is important for functionally 
mature FRCs and a role for T cells has been proposed to be implicated in the expansion of the 
T zone, the factors involved in constructing and expanding the T zone remain largely elusive 
in most studies.  
1.4.3.2 Formation and maintenance of B cell follicles 
FDCs are critical in establishing follicle identity as illustrated by their ablation and the 
subsequent loss of the follicle compartment162. B cell-derived TNF-α and LT were shown to be 
important for the generation of FDCs 163-165. Formation of B cell follicles was shown to directly 
depend on a positive feedback loop between B cells and FDCs, and strongly depends on 
expression of FDC-derived CXCL13. B cell attraction and retainment is driven by the B cell-
expressed CXCR5 receptor for the CXCL13 chemokine. CXCR5 signaling stimulates the 
expression of LT on B cells that subsequently engage with LTβR on FDCs, which in turn 
stimulates the further expression of CXCL13166. Stimulation of LTβR on FDCs is crucial during 
post-development as blocking LTβR signaling in FDCs leads to the disappearance of the 
stromal cell population and follicle structure154. 
1.4.3.3 Formation and maintenance of HEVs 
HEVs are critical for naïve and memory lymphocyte homing into lymph nodes and overall 
lymphocyte recirculation. After birth, HEVs promote lymph node volume expansion via naïve 
lymphocyte recruitment70,167,168. This process was shown to depend on the arrival of retinoic 
acid producing DCs from the gut. These DCs, after stimulation by gut commensal microbes, 
induce the switch of neonatal expressed MadCAM-1 (receptor for integrin α4β7) to PNAd 
(receptor for CD62L) in peripheral lymph nodes and allow the further recruitment of 
lymphocytes and volume expansion in these organs70. 
DCs are also critical for maintaining the phenotype and function of HEVs in homeostatic 
conditions what relies on LTβR signaling. These signals were shown to come from DCs as 
ablation of DCs in adult mice leads to loss of HEV phenotype and subsequent reduced size 
and cellularity of LNs169. Due to constant immune cell trafficking through the endothelium, 
blood including platelets leak out of HEVs, and HEV integrity further depends on interactions 
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with these platelets. PDPN+ FRCs surrounding the HEV activate platelets by engagement of 
their C-type lectin domain family 1 member B (CLEC-2) surface receptor, inducing S1P release 
by platelets which promotes vascular integrity by promoting the expression of HEV tight-
junction molecules170.  
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2 Swelling and remodeling of the reactive lymph node 
 
Immunization leads to the rapid swelling and remodeling of the draining lymph node, also 
referred to as the reactive lymph node, and is a hallmark of adaptive immunity in which 
extremely rare cognate T and B cells are clonally selected and amplified, and GCs are formed 
to produce high-affinity antibodies49,54,171-173. Clinical presentations of swollen lymph nodes 
are characterized as palpable enlarged but tender, and experienced as painful. During the 
swelling process, the stromal cell network within the organ rapidly changes to support the 
different facets of the adaptive immune response. Swelling of the reactive lymph node has 
important functions that accommodate the immune response. 
 
First, rapid swelling increases the T cell and B cell repertoire by 5-10x and increases the 
number of interactions between DCs and cognate T cells, improving the quality and the time 
necessary to mount a response37,49. This is important in limiting the time for invading 
pathogens to spread. Second, after initial DC-cognate-T cell interactions, subsequent immune 
cell interactions are required in the adaptive immune response. To increase the likelihood of 
these interactions, additional streamlining within an ever-growing organ is necessary (e.g., 
after Th cell stimulation by DCs, primed Th cells and licensed DCs interact with cognate CD8+ 
cells and require repositioning. Tfh cells have to reposition to follicle borders to interact with 
cognate B cells and receive IL-6 to further mature). These activated cells require further 
stroma effector functions that provide the right stimuli and promote search strategies to 
support their interactions, most of which are provided by the remodeled stromal 
network44,174. Third, a tightly coordinated orchestration of B cells, Tfh and stromal cell 
interactions is required to produce high affinity antibodies, which entails extensive 
remodeling of the follicular stromal backbone into a GC138.  
 
Failure to maintain an intact stromal network during the immune response abrogates the 
immune response, underlining the importance of these stromal cells in the process86,88,89. In 
the following chapter, I will discuss what is driving the swelling of the lymph node and how 
the internal stromal network is remodeled to support the immune response. 
 
2.1 Initial swelling of the lymph node  
The lymph node is an extremely dynamic organ in which the whole lymphocyte population, 
making up about 98% of the whole organ cellularity, is turned over approximately 2-4 times 
per day. Initial swelling of the lymph node can be understood as an adaptation of influx and 
efflux dynamics of lymphocytes. DCs and lymphocytes constantly recirculate the body and 
enter the lymph node parenchyma from the blood via HEVs and to a lesser extent from the 
lymph via afferent lymphatic vessels by following CCL19 and CCL21 chemokine gradients. 
After residing 6-12h within the node, lymphocytes leave the organ again via efferent 
lymphatic vessels by following LEC-derived S1P37,167. 
 
Influx and efflux dynamics, and therefore lymph node size, are controlled at multiple levels 
and depend on circadian regulation of lymphocyte CCR7 expression and tissue homeostatic 
chemokine secretion, afferent lymph flow, arterial blood flow through the organ, lymphocyte 
CCR7 de-sensitation and S1P re-sensitation, and HEV presentation of adhesion molecules and 
chemokines175,176. Furthermore, HEVs might also have a role in regulating the lymph node size 
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by limiting the influx rate of T cells by acting as waiting areas for T cells to enter the 
parenchyma124.  
 
Upon inflammation, the influx and efflux dynamics of immune cells change drastically in a 
sequence of events. Initially,  the lymph node goes into a shutdown mode in which 
lymphocytes are retained within the organ as a result of downregulation of the S1P exit 
receptor172,177. Around the same time, afferent lymphatic drainage is enhanced and coincides 
with the arrival of greater number of DCs as well as pro-inflammatory cytokines178. This 
results in (1) fever-mediated increased adhesion ligand surface expression on lymphocytes, 
(2) enhanced presentation of adhesion molecules on HEVs, (3) increase in HEV permeability, 
and (4) presentation of inflammatory chemokines, derived from other regions of the lymph 
node or peripheral tissues, on HEVs, which together result in increased homing of immune 
cells into the reactive lymph node179-183. This process is also accompanied by the remodeling 
of the blood vasculature, including HEVs, and DC-mediated remodeling of the feeding 
arteriole, to further enhance blood perfusion through the organ and keep up with the growing 
metabolic need, while further enhancing homing of lymphocytes into the organ 184-191. In the 
initial phase, the influx of migratory DCs also relaxes FRCs and help to provide space for naïve 
lymphocytes to enter187,188. Later in inflammation FRCs proliferate more significantly and 
expand the FRC network to create space for homing immune cells and activated and 
proliferating cells within the organ 186. Together, these processes result in increased immune 
cell cellularity and expansion of the stromal backbone, which drive the swelling of the lymph 
node.  
 
2.2 Stromal expansion and remodeling in the reactive lymph node 
Following the initial swelling of the reactive lymph node, the stromal backbone starts to 
expand to accompany the growth of the growing organ and to form specialized niches to 
support the immune response. Some processes in this expansion have been well 
characterized and rely on the interactions of stromal cells and immune cells. HEV and 
lymphatic vessel expansion relies on B cells and is vascular endothelial growth factor (VEGF) 
independent, while growth of the other vascular structures relies on VEGF secretion by FRCs 
mediated via LTβR and IL-1β stimulation by DCs178,192-195. Expansion of the vasculature in the 
lymph node arises from pre-existing HEVs where endothelial cell proliferative units clonally 
expand and can both elongate HEVs and sprout new capillaries196. Furthermore, remodeling 
of the reactive lymph node is characterized by maturation of B cell follicles that form a GC 
and relies on increased FDC LTβR signaling as activated antigen-bearing B cells upregulate LT 
upon co-stimulation from helper T cells197,198. In some acute immune responses, homeostatic 
chemokines are downregulated in reactive lymph nodes and borders between the follicles 
and T zone additionally become vaguer due to the expansion of VSCs that reside at the outer 
border of follicles142,199.  
 
Expansion of TRCs and the conduit network in reactive lymph nodes remains only partly 
understood. However a substantial amount of work has provided clues that TRC expansion is 
likely controlled by multiple mechanisms that are partly redundant. It is established that in 
vitro TRC production of extracellular matrix requires interaction with T cells155,159. In general, 
newly formed FRCs are suggested to derive from either a stromal precursor or terminally 
differentiated FRCs proliferating in the local lymph node200-202. In inflammatory conditions, 
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FRCs transiently alter their gene expression and require in some settings metabolic 
programming via IL-17 to potentiate proliferation, but rely on additional signals for their 
proliferation94,203,204.  
While after certain types of vaccinations FRC proliferation is induced rapidly186,202, in other 
immune responses FRC proliferation in the reactive lymph node is delayed and is only 
extensive observed after a few days of inflammation, following an initial volume expansion 
proposed by relaxation and stretching of the TRC network and only modest proliferation of 
FRCs186-188. DCs have been implicated in FRC expansion as their ablation during mid-
inflammation diminishes the proliferation of TRCs. However, these effects are most likely 
secondary to the loss of lymphocyte cellularity as their presence is needed to maintain HEV 
phenotype and support lymphocyte recirculation186,205.  
 
Additional roles for DCs have been described regarding TRC expansion. First, actomyosin 
relaxion in TRCs induced by an antagonistic anti-PDPN antibody resulted in proliferation of 
TRCs in vivo and as such signals are physiologically provided by DCs it potentially could induce 
proliferation of TRCs in the early phase of lymph node swelling188,206. Second, blocking of DC 
derived IL-1β or knock, which accumulates in the reactive lymph node during initial swelling, 
blocks early TRC proliferation186,195. In addition, interaction between DC-derived LTβR ligands 
and FRC-expressed LTβR was shown to play a role in survival of FRCs by upregulation of PDPN 
and subsequent enhanced integrin-β1-mediated adhesion to the extracellular matrix in the 
reactive lymph node, but not in homeostatic conditions206. Together, DCs are important for 
the initial swelling of the lymph node by providing stimuli that facilitate relaxation of FRCs 
and their early proliferation. DCs also maintain HEV phenotype and vascular expansion to 
support further lymphocyte accumulation, and play a role in the later phase of lymph node 
swelling by supporting FRC survival. Homing of lymphocytes into the reactive lymph node has 
been established as crucial to drive the expansion of the stromal network where they provide 
LT signals to FRCs and HEVs169,186,192,207. B cells have also been implicated in the maintenance 
of reactive lymph node size as mice lacking all B cells show a premature contraction of the 
TRC network203.  
 
Interestingly, proliferation of homeostatic T cells in the absence of inflammatory signals has 
been shown to be enough to drive FRC expansion186. Increase of cellularity within the organ 
conceivably leads to increased strain on the capsule and FRC network. Since the FRC and 
lymphocyte compartment size ratio remains stable during the swelling of the reactive lymph 
node, mechanical regulation of FRC expansion and/or cellularity of the organ could be an 
elegant solution to link both compartment sizes and ensure optimal growth dynamics186. To 
understand the role of mechanical stimuli, forces acting on tissues and cells are needed to be 
characterized and understood in their biological and physiological context. Therefore, the role 
of mechanical forces in growth of tissues and their measurement tools are further discussed. 
 
2.3 Tissue growth and measurement of forces 
Lymph nodes and spleens are unique in their capacity as post-natal organs to grow 
significantly in the order of days. Developmental processes, such as gastrulation or the 
development of teeth, muscle and the myocardium are driven by mechanosensation as well 
as mechanotransduction, and form perhaps the closest analogy to a swelling lymph node208. 
Mechanical stimuli have been implicated in positioning of cells, transcriptional regulation and 
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subsequent cell fate specification by forming mechanochemical feedback loops208,209. 
Characterization of such mechanosensation and mechanotransduction roles involves the 
identification and quantification of forces acting on tissues.  
 
It is useful to think of biological tissues as materials which can behave elastic and/or viscous 
under mechanical load. A material is elastic when it returns to its original shape after 
deformation and is viscous when the original shape cannot be maintained (plastic 
deformation). The stiffness of a material (Young’s Modulus or elasticity) is defined by the 
degree to which forces (stress) produce a deformation (strain); a tissue with a high Young’s 
modulus deforms less under a fixed load when compared to a tissue with a low Young’s 
modulus. Biological tissues behave viscoelastic, meaning their behavior can be described by 
both an elastic and viscous component, which critically depends on the rate at which a force 
is applied: at short, tissues behave as an elastic solid, while at longer timescales, as a viscous 
liquid210. These behaviors can be further ascribed to cell-cell adhesions, cell-matrix adhesion, 
and cell intrinsic properties (e.g., contractility) 208. Additionally, properties of various 
extracellular matrix structures can also have an effect on tissue behavior: fibrillar collagen 
behaves viscoelastic and undergoes strain-stiffening, the reversible phenomena involving an 
increase of the Young’s modulus under higher strains, while elastin behaves elastically. 
 
Multiple tools have been developed to assess the behavior of biological materials210. By 
combining multiple approaches, in which tissue properties are investigated from different 
angles, a clear picture of how a biological tissue behaves and to what this behavior is 
attributed can be deciphered. To this end, parallel plate compression experiments in which a 
tissue is deformed between two surfaces at a fixed strain have been used. Tissues relax under 
a fixed strain and remodel their internal forces elastically in the short time scale and as a 
viscous liquid in the longer time scale, and can be accurately described by a generalized Kelvin 
model of viscoelastic behavior211. These measurements yield information about relaxation 
times, spring and friction constants of the elastic and viscous components, as well as the 
surface tension, viscosity, and the Young’s modulus211. Micro-pipette assays have also been 
used to obtain useful information about tissue behavior212. In these experiments a 
micropipette is placed onto or into a tissue upon which a defined negative pressure is applied 
in the pipette that results in aspiration of the assessed tissue. Compared to parallel plate 
compression experiments, the stress is kept constant in these experiments as opposed to a 
constant strain. Aspirated tissues show a fast elastic deformation and a slower viscous 
deformation that, together with the geometry of the aspirated tissue, can be modeled using 
the Laplace law to obtain information about the surface tension, viscosity and Young’s 
modulus212. When the pipette diameter is relatively small compared to the measured tissue 
or individual cell, the local Young’s modulus (local tissue property) is measured as opposed to 
measuring the overall elasticity of the measured cell or tissue. This is in analogy with 
measuring the local Young’s modulus by making an indentation on the cell wall by an atomic 
force microscope tip213. Tension can also be directly measured by surgically cutting tissue 
structures with a high-pulsed ultra-violet (UV)-laser214,215. Tissues under tension will show a 
recoil, and recoil speeds can be directly compared with one another when cutting parameters  
are similar. These measurements are in analogy with a rubber band: the more the band is 
under tension when stretched, the faster it will recoil after it is cut. In addition, if the viscous 




The aim of this study is to elucidate how the lymph node is able to swell in volume within the 
order of days. The trapping of recirculating lymphocytes is expected to have a significant 
effect on the tension of the reactive lymph node.  
 
The role of mechanical forces in the reactive lymph node remains elusive. This study 
investigates how different forces within the lymph node arise, are distributed, and change 
over time, and further characterizes their effect on swelling of the reactive lymph node. 
Furthermore, how the FRC network is able to cope with the rapid increase in volume during 
inflammation is only partly known and is further investigated by characterizing how and 
where the stromal network is expanding. Typically, studies into remodeling of SLO have 
focused on interactions between immune cells and stromal cells. This study decided to move 
away from this paradigm and view the growth of the lymph node in mechanical terms. To this 
end, specific force probing tools, pharmacological inhibitions and fate mapping are used to 
measure forces on the whole organ as well as on capsular and stromal network components , 
and investigate how the FRC network is growing in the swelling lymph node. Additionally, a 
FRC conditional genetic loss of function approach was employed to interfere with FRC 
contractility to dissect the role of FRC generated forces on lymph node swelling and stroma 
network expansion. This approach enables the dissection of important components that are 
permissive to- and restrict reactive lymph node swelling, giving insight in their effect on 
remodeling of the organ, and provide clues into how the growth of the organ is regulated and 
eventually halted. Importantly, it provides a new view of how physical forces in the lymph 
node are affected by lymphocytes, and can provide insights in the interplay of stroma 
contractility and lymphocyte homing. Therefore, this study is expected to demonstrate 
whether there is a mechanical feedback between stroma contractility and lymphocyte 
homing in the swelling lymph node, and have the potential to elucidate how the lymphocyte 
and FRC population are tightly regulated. We hypothesize that the rapid increase of 
lymphocytes induces pressure in the organ which is resisted by the capsule and FRC network 
and affects the swelling rate of the lymph node. The Interference with resisting forces could 
therefore lead to an altered lymph node swelling dynamic. 
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2.5 Results  
2.5.1 The physical properties of the lymph node change in inflammation 
Lymph nodes are drastically changing their size and internal structure in inflammation. We 
therefore asked if these changes lead to altered tissue properties in the lymph node swelling 
process.  
Upon immunization with Keyhole Limpet Hemocyanin (KLH) antigen in Complete Freud’s 
Adjuvant (CFA) in footpads of wild-type (wt) mice, we observed a more than 10-fold increase 
in volume of draining popliteal lymph nodes after 14 days, when the lymph node reaches its 
maximum size (Figure 4A,B) 185. The volume was calculated from two-dimensional (2D) side-
view images that correlated well with the weight of the organ (Figures 4C,G).  
To study the general tissue behavior of the popliteal lymph node in homeostatic conditions 
and at different inflammation timepoints, we used a parallel plate compression approach, in 
which a lymph node is compressed and maintained at 25% of its original height (fixed strain), 
while the resisting force is measured on the top plate over a typical time period of 20-40 
minutes (Figure 4D,E). During this time the lymph node undergoes a viscoelastic relaxation 
behavior in which the tissue internally remodels its forces to reach a new equilibrium state, 
which is described by the stress-relaxation curve (Figure 4E). The curve follows a double-
exponential decay dynamic that was fitted to measure the decay parameters (A1, A2, τ1 and 
τ2) and the force at equilibrium (Feq) (Figure 4E,F). Using the geometrical parameters of the 
lymph node (L, R1, R2 and R3) measured at either start or equilibrium (Figure 4D) we derived 
the elastic modulus (E or Young’s Modulus, further referred to as elasticity), the viscosity, and 
the effective resistance (σ) of the tissue by modelling the parameters to a generalized Kelvin 
model (Figure 4D-G). This model describes the stress-relaxation behavior of the tissue by its 
elastic and viscous components. At equilibrium, the external force by the plate is resisted by 
the effective resistance of the lymph node (given in µNewton/µm). The elasticity (given in 
µNewton/µm2 or Pascal (Pa) represents the resistance to deformation by a certain force for 
a solid elastic and works on the short time scale (order of seconds in the lymph node), and 
viscosity (given Newton*meter*minute) the resistance to deformation of a fluid which acts 
on the long time scale (order of minutes in the lymph node). While the elastic modulus solely 
depends on the equilibrium force, strain and contact area, the viscosity and effective 
resistance also take into account the viscoelastic relaxation and geometrical parameters  
(Figure 4G). The effective resistance is the most informative parameter as it directly describes 
the forces that resist the swelling of the organ; it describes how much force is necessary to 
deform a tissue by a certain length. In the original study that developed the model as 
described above, the effective resistance is the surface tension in their embryonic tissue 
model system211. In the case of the lymph node which has a capsule (elastic shell) and a dense 
sponge-like contractile FRC network, this parameter can be best described as the combination 
of resisting forces from both the capsule and FRC network, and hence was named effective 
resistance. When measuring the effective resistance and elasticity at homeostasis (day 0; D0) 
and at inflammatory timepoints (day 2 to day 14; D2-D14), we observed a ~4-fold increase of 
effective resistance and ~2-fold increase of elasticity during inflammation (Figure 4I,J). These 
values stay elevated until the endpoint at D14. Furthermore, we found that the viscosity 
remains stable at the early timepoints after onset of inflammation and increases by about 5-
fold at D8 and stays elevated until D14 (Figure 4K). All together, these data show that tissue 
properties are changing in inflammation as the FRC network and capsule are presumably 
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resisting the swelling of the organ. Next, we investigated further how these changes in tissue 
behavior arise.  
 
Figure 4. Lymph node swelling changes tissue properties.  
A-C, Volume as calculated from 2D side-views and weight increase of popliteal lymph node in inflammation. 
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Linear regression l ines are drawn in B-C. Scale bar = 400 µm. D, Geometrical parameters measured before 
compression and at equil ibrium. Scale bars = 300 µm. E-F, Stress relaxation curve following compression and 
force fitting curve. Measured timepoints and parameters are indicated. G, Overview of the generalized Kelvin 
model and formulas used to derive physical properties plotted in (B, I-K). H, Viscoelastic curves of all  measured 
timepoints. mean±SEM are plotted per timepoint. I-K, Effective resistance, elasticity and viscosity of parallel 
plate measured popliteal lymph nodes in homeostasis and inflammation. Each point represents a measured 
lymph node. I, Effective resistance. Kruskal-Wallis test (Chi square = 19.83, df = 4, ***, p=0.0005). Dunn’s post-
hoc test. J, Elasticity. Kruskal-Wallis test (Chi square = 9.787, df = 4, *, p=0.0442). Dunn’s post-hoc test. K, 
Viscosity. Kruskal-Wallis test (Chi square = 16.42, df = 4, **, p=0.0025). Dunn’s post-hoc test. All  bars represent 
mean±SEM. 
 
2.5.2 Lymphocyte cellularity dictates the tissue behavior in homeostasis and 
inflammation 
Lymph node swelling is driven by a massive influx of naïve T cells. To better understand the 
change in lymph node tissue behavior in inflammation timepoints we next looked more 
carefully how cellularity is affecting the size, effective resistance, elasticity and viscosity. 
Lymphocytes are constantly recirculating the body. They enter the lymph nodes from the 
blood via HEVs into the parenchyma and exit the lymph node again after several hours via 
efferent lymphatic vessels, turning over the whole lymphocyte population multiple times per 
day (Figure 5A). We first perturbated the cellularity of the homeostatic lymph nodes to 
address how changes in cellularity affect the volume, elasticity, effective resistance and 
viscosity as measured by parallel plate compression. To this end, we treated wt mice with 
either anti-CD62 ligand (𝛼𝛼-CD62L), FTY720 compound or phosphate buffered saline (PBS) as 
a control, and measured the tissue behavior of popliteal lymph nodes 24 hours later by 
parallel plate compression. 𝛼𝛼-CD62L blocks the L-selectin ligand on recirculating lymphocytes 
and interferes with their homing capacity via HEVs, while FTY720 administration results in the 
internalization of the S1P1 receptor preventing lymphocytes from exiting the lymph node via 
efferent lymphatics (Figure 5A). These treatments effectively interfered with observed tissue 
behavior and lymph node size (Figure 5B). A decreased volume and weight of lymph nodes 
could be observed after 𝛼𝛼-CD62L treatment (Figure 5C, D), and furthermore resulted in 
reduced elasticity, effective resistance and viscosity compared to controls (Figure 5E-G). 
Treatment with the FTY720 compound did not increase the volume or weight of the lymph 
node, but weight showed less deviation as compared to control (Figure 5C,D). 
 
In turn, lymph nodes from FTY720-treated mice showed a trend towards increased effective 
resistance and elasticity of the lymph node when compared to controls (Figure 5E,F). At the 
same time, viscosity was reduced in these mice, indicating that this parameter most likely 
depends on additional factors besides cellularity (Figure 5G).  
 
Together, these experiments show that by using pharmacological intervention, cellularity of 
lymph nodes can be reduced and directly affect lymph node size and tissue behavior. 
Especially, the decrease in effective resistance is interesting as it argues that it would be easier 
for cells to enter into a more emptied lymph node. Lymph nodes of mice treated with anti-
CD62L were not completely emptied and indicate that the cellularity is possibly kept at a 
minimum number where cells are not able or instructed to leave the lymph node any further. 
A previous study has shown that 5 days after anti-CD62L treatment only 9% of lymphocytes 
were still present in peripheral lymph nodes with lymphocyte subset composition altered, 
while the number of lymphocytes in the spleen were drastically increased216. 
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FTY720 prevents lymphocytes from exiting the lymph node and simultaneously, cells homing 
from blood might be expected to keep on entering the organ. However, treatment with 
FTY720 did not result in swelling of the lymph node. These findings are in line with a previous 
report that shows that homing lymphocytes are increasingly sequestered in HEV pockets 
upon FTY720 treatment, indicating that the homeostatic lymph node cellularity and therefore 
size is likely capped. Therefore, we do not draw any conclusions on tissue behavior based on 
FTY720 treated mice since FTY720 does not effectively increase cellularity and lymph node 
swelling124. 
 
Next, we asked how cellularity is affecting the tissue behavior of lymph nodes following 
footpad immunization with KLH/CFA. Four days after immunization, significant swelling of the 
organ takes place which is driven by a massive influx of lymphocytes and proliferation of 
activated cognate T cells. In order to distinguish between contributions of those two 
components, we treated wt or OT-II mice with either 𝛼𝛼-CD62L or PBS at the onset of 
inflammation and measured the tissue behavior of draining popliteal lymph nodes after four 
days (Figure 5H). Mice with an OT-II background suppress their original TCRs and express a 
transgenic TCR that is specific for the chicken ovalbumin peptide in the context of the CD4 co-
receptor interaction with MHC class II217. Thereby, we created a mismatch between the 
antigen (KLH) and TCR specificity (OVA), resulting in a situation where in theory no T cells are 
antigen-specific and are not able to be primed, while homing of naïve lymphocytes remains 
unaffected. Treatment with 𝛼𝛼-CD62L should prevent naïve lymphocytes from homing into the 
organ during the swelling period (Figure 5H).  
 
As measured by parallel plate compression, these treatments have a direct effect on tissue 
behavior and observed lymph node size (Figure 5I-M). Wt lymph nodes swell significantly 
during the first four days of inflammation, whereas the absence of proliferating T cells in OT-
II mice results in shows a trend towards smaller lymph node volumes (Figure 5J). Treatment 
with 𝛼𝛼-CD62L further reduced the volume both in wt and OT-II mice. The combined effect of 
absence of proliferating T cells and block of homing reduced the volume of lymph nodes to 
almost homeostatic levels (Figure 5J). In agreement with the findings in the homeostatic 
lymph nodes, reduced swelling upon inflammation shows a trend in which the effective 
resistance is also decreased (Figure 5K). This indicates that increased lymph node cellularity 
in homeostasis and inflammation could induces pressure on the backbone of the lymph node, 
thereby increasing the resistance to growth. The elastic modulus and viscosity did not show 
a clear trend with lymph node size (Figure 5L, M).  
 
These results suggest that lymphocyte cellularity is driving the swelling of the lymph node and 
could increase the resistance to swelling. Both lymphocyte proliferation and naïve 
lymphocyte homing contribute. Next, we sought to characterize how the FRC network as a 
resisting component of growth is involved in lymph node swelling. 
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Figure 5. Cellularity dictates tissue behavior in homeostasis and inflammation. 
A, Schematic overview of manipulation of cellularity under homeostatic conditions. Lymph nodes were treated 
with 𝛼𝛼-CD62L or FTY720 to reduce and increase lymphocyte cellularity, respectively. Lymph nodes were 
measured 24h after treatment by parallel plate compression. B, Side-view of treated and control popliteal 
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lymph nodes before compression and their respective stress-relaxation curves. Scale bars = 200 µm. C, 
Estimated volume popliteal lymph nodes. One-way ANOVA (F (2, 20) = 9.962, ***, p=0.001), Dunnett’s post-
hoc test. D, Weight of popliteal lymph. Brown-Forsythe ANOVA test (F (2, 4.776) = 12.96, *, p=0.0118). 
Dunnett’s post-hoc test. E-G, Tissue parameters derived from parallel plate compression experiments in 
homeostatic conditions. E, Effective resistance. One-way ANOVA (F (2,20) = 5.083, *, p=0.0164), Dunnett’s 
post-hoc test. F, Elasticity. One-way ANOVA (F (2,20) = 4.243, *, p=0.0291) Dunnett’s post-hoc test. G, 
Viscosity. One-way ANOVA (F (2,20) = 2.426, ns, p=0.1140), Dunnett’s post-hoc test. H, Schematic overview of 
manipulation of lymph node cellularity in inflammation. I, Side-view of treated and control popliteal lymph 
nodes before compression and their respective-stress-relaxation curves. Scale bars = 400 µm. J-M, Tissue 
parameters derived from parallel plate compression experiments in inflammatory conditions. Red dashed line 
indicates homeostatic values as measured in Figure 4. J, Volume. Kruskal-Wallis test (Chi square = 18.56, df = 3, 
***, p=0.0003). Dunn’s post-hoc test. K, Effective resistance. Kruskal-Wallis test (Chi square = 9.969, df = 3, *, 
p=0.0187). Dunn’s post-hoc test. L, Elasticity. Kruskal-Wallis test (Chi square = 3.125, df = 3, ns, p=0.3726). 
Dunn’s post-hoc test. M, Viscosity. Kruskal-Wallis test (Chi square = 4.463, df = 3, ns, p=0.2156). Dunn’s post-
hoc test. Each dot represents a measured lymph node. All  bars represent mean±SEM. 
 
2.5.3 Conduits are stretched in inflammation 
The conduit network forms a dense interconnected 3D network of extracellular matrix 
throughout the lymph node and forms a tight connection to the SCS. Thus, the rapid swelling 
of the lymph node following inflammation requires the conduit network to adapt. Since the 
main force-bearing component of the conduit is fibrillar collagen type I, we investigated how 
this extracellular matrix component is structurally adapting and whether it plays a role in 
increasing the effective resistance as it is putatively strained by the increased lymphocyte 
cellularity.  
 
We reasoned that if conduits are bearing more force in inflammation, their fibrillar collagen 
component becomes increasingly aligned when tension on the conduit network increases. To 
this end, we analyzed the structural 3D organization of fibrillar collagen of the conduit 
network in homeostasis and after two, four and fourteen days of inflammation following 
immunization with KLH/CFA (Figure 6A-F). To be able to study the fibrillar component without 
interference of cellular structures, lymph nodes were first alkali-macerated after fixation, 
leaving in place only the fibrillar collagen component, and were subsequently contrast 
enhanced and sliced for scanning transmission electron microscopy (STEM;Figure 6A). 
Tomograms of conduits were made by tilting the sample from -76° to +76° and images were 
acquired at every 2° tilting step (Figure 6B). Using computed weight back projection, the 3D 
image of the conduit was reconstructed and the background removed for further analysis 
(Figure 6C). Fibrils were manually traced in 3D and the centerline of the conduit direction 
computationally calculated. This allowed determining the extent to which the individual fibrils 
are aligned with the conduit centerline and how straight the individual fibrils are (Figure 6D). 
We found that early on in inflammation, the collagen fibrils are progressively aligned 
compared to the homeostatic situation and go back to homeostatic levels of alignment after 
two weeks of inflammation when the maximum size of the lymph node is reached (Figure 6E). 
In agreement with this, fibrils were also straightened after four days of inflammation and 
returned back to the homeostatic situation two weeks after the onset of inflammation (Figure 
6F).  
 
Together, these results show that conduits are increasingly bearing mechanical load after 
onset of inflammation, which returns back to a homeostatic load-bearing regime when the 
lymph node reaches its maximum size. Since FRCs are tightly adherent to the conduit 
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network, we next investigated how FRCs are affected by the increase of mechanical load on 
the conduit network. 
 
 
Figure 6 Structural collagen fibril conformation of the lymph node conduit.  
A-C, Steps of tomography workflow. A Schematic overview of sample preparation. B, Il lustration of tomogram 
STEM acquisition of conduit extracellular matrix and examples of different ti lt angles. C, Il lustration of 3D 
reconstruction from tilting angles images via computed weight back projected and subsequent background 
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removal. D, 3D view of tomograms, tracked fibrils and centerline of conduit in homeostasis and different 
timepoints following inflammation. E, Il lustration of spine alignment quantification. F-G, Quantification from 
fibril  tracking experiments Each dot represents the average value per conduit (n=7-8 per timepoint). Between 
176 and 526 individual fibrils were measured per timepoint. Bars represent mean±SEM. F, Quantification of 
collagen fibril alignment to centerline of conduit. Kruskal Wallis test (Chi square = 11.72, df = 3, **, p=0.0084). 
G, Quantification of collagen fibril straightness. Kruskal Wallis test (Chi square = 11.27, df = 3, *, p=0.0104).  
2.5.4 FRCs experience tension dynamics 
FRCs are myofibroblasts that are believed to tightly enwrap and contract the conduit network. 
In general, cells are able to sense the mechanical forces on the environment (e.g. a strained 
stiffer collagen substrate) by contracting their environment and transmitting forces via 
integrins and talin adaptor molecules onto the cytoskeleton. This in turn leads to a force 
balance between cell-derived traction forces and the underlying extracellular matrix218,219.  
 
To study if the observed change in conduit conformation has an effect on FRC contractility, 
we directly measured the active tension on the FRC network using UV-laser cutting 
experiments. To this end, we surgically exposed the inguinal lymph node of CCL19-Cre hem 
mTmG hom mice in which only FRCs express a membrane-coupled GFP (mGFP). We then 
imaged the subcapsular cortical FRC network typically around 15 µm underneath the capsule, 
using a spinning-disc microscope setup equipped with a high-power UV-laser. This laser was 
used to cut the FRC network, which resulted in the recoil of the network, indicating tension 
on these structures (Figure 7A). Using kymographs along the recoil axis, we were able to 
measure the speed of the recoil, which is a direct measurement of the tension (Figure 7B).  
 
To address how the tension on the FRC network is changing upon inflammation, we 
performed UV-laser cutting experiments in homeostasis and several timepoints upon 
inflammation and analyzed recoil velocities (Figure 7C, D ). We found that tension on the FRC 
network indeed increases in inflammation, but is delayed from the alignment of the conduit 
collagen network which is increasingly aligned from day two of inflammation (Figure 6E), 
while FRC tension is going up at day four of inflammation and stays elevated throughout the 
further growth phase of the lymph node (Figure 7E). In agreement with the conduit collagen 
conformation experiments, FRC tension is again reduced to homeostatic levels two weeks 
after onset of inflammation, when the maximum size of the lymph node is reached and the 
conduit collagen network returns to the homeostatic conformation (Figures 6E, 7E).  
 
To confirm that tension increases on FRCs after inflammation, we looked at the nuclear 
localization of the transcription factors Yes-associated protein (YAP), and transcriptional co-
activator with PDZ binding motif (TAZ), as they were shown to translocated to the nucleus 
upon increased tension220. We found that FRCs (labeled with mGFP) and endothelial cells 
stained positive for YAP/TAZ, while no signal could be found in lymphocytes (Figure 7F). By 
quantifying the ratio of YAP/TAZ signal in FRCs between the nucleus and adjacent cytoplasm 
in thick vibratome sections of the deep paracortex, we were able to measure the nuclear to 
cytoplasmic (N:C) YAP/TAZ ratio (Figure 7G). The N:C ratio of YAP/TAZ in FRCs is increased in 
inflammation, showing conclusively that FRCs are experiencing increased tension during 
lymph node swelling. The N:C ratio of YAP/TAZ decreased when the maximum size of the 
lymph node was reached (Figure 7H). Importantly, these dynamics follow the measured 
tension from the UV-laser cutting experiments (Figure 7G,H). Interestingly, after two weeks 
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of inflammation we also observed a population of FRCs that had a negative N:C ratio, 
indicating those cells were not experiencing active tension (Figure 7H).  
 
Together, these data show that conduits are becoming more stretched in inflammation. In 
turn FRCs are sensing the increase in substrate-rigidity and start contracting more to balance 
the forces which results in higher recoil velocities and N:C YAP/TAZ ratio. Furthermore, the 
tension increase is transient and when the lymph node stops growing, conduit conformation 
and FRC tension are back to homeostatic levels. Next, we investigated how the swelling of the 





Figure 7. Tension measurements on the FRC network. 
A, Overview of the UV-laser cut experiment of the FRC network measured in surgical exposed inguinal lymph 
nodes from CCL19-Cre GT26Sor mice. Arrows indicate location of cut and recoil  of FRC network. Dashed lines 
indicate axis along which kymographs are typically created. Scale bars = 20 µm. B, Schematic i l lustration of 
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analysis of recoil  velocities from kymographs. C, Representative examples of FRC network UV-laser cuts at 
homeostasis and various timepoints after inflammation. Arrows indicate location of cut and recoil  of FRC 
network. Scale bars = 5 µm. D, kymographs from respective examples from C. Dashed lines indicate the slopes 
that were used to measure recoil  velocities. Scale bar x-axis = 1 s, scale bar y-axis = 2 µm. E, Quantification of 
recoil  velocities of FRC network in homeostasis and inflammation. Each dot represents an individual cut. 
Between 20 and 51 cuts per timepoint were measured. Data is pooled from 2 experiments. n=3 animals per 
timepoint. Welch ANOVA (Chi square = 21.75 (4, 130.5), ****, p<0.0001), Dunnett’s post-hoc test. F, 3D view of 
the FRC network from a CCL19-Cre; mTmG mouse in which FRCs are labeled with mGFP and stained for YAP/TAZ. 
Stack size 20 µm. Scale bars = 20 µm. G, Representative examples of YAP/TAZ nuclear and cytoplasmic 
localization. H, quantification of YAP/TAZ N:C intensity ratio. The dashed line shows the ratio of 1 where 
intensities between nucleus and cytoplasm are equal. Each dot corresponds to a measurement of a single cell. 
Between 19 to 48 cells were measured per timepoint. Measurements were taken from at least two different 
vibratome slices per lymph node (n=3, analyzed lymph nodes). Kruskal-Wallis test (Chi square = 105.1 (df =4, 
****, p<0.0001), Dunn’s post-hoc test. All  bars represent mean±SEM. 
 
 
2.5.5 Characterization of FRCΔTalin1 mice 
FRCs are experiencing increased tension in the swelling lymph node following immunization 
by KLH/CFA. Even in homeostasis, FRCs are actively contracting the lymph node. We therefore 
investigated the effect of impaired FRC mechanosensing and consequently impaired 
contractility on homeostatic lymph nodes and the swelling process. 
 
To this end, we generated CCL19-Cre; Talin1floxed mice in which talin1 – but not the talin2 
isoform – is conditionally ablated in FRCs (further on referred to as FRCΔTalin1). Talin1 and talin2 
have been implicated in differential mechanoperception, cells would therefore perceive the 
environment as less stiff when forces are coupled to the cytoskeleton via talin2 as compared 
to talin1221. Ablation of talin1 in FRCs would selectively impair mechanoperception while still 
allow FRCs to adhere to the conduit extracellular matrix as well as maintain integrin signaling 
via talin2. First, we characterized these mice under homeostatic conditions. 
 
FRCΔTalin1 mice develop all skin-draining lymph nodes, spleen and thymus, although all 
characterized SLO are significantly reduced in size (Figure 8A). Upon further inspection, we 
found that the T zone of these mice is significantly reduced (Figure 8B). A large area of the 
lymph node is rich in lymphatic vessels, suggesting that most of the FRC network could 
resemble a medullary FRC network at the cost of the T zone (Figure 8C). The FRCΔTalin1 network 
formed in the T zone has FRC protrusion still covering ERTR7 fibers, and resemble the wt 
network (Figure 8C). However, many atypical PDPN+ FRCsΔTalin1 network regions can be found 
that formed a dense network of ERTR7+ reticular fibers (Figure 8E). Lymph nodes are further 
deprived of CCL21, while HEVs still express the homeostatic chemokine CCL21, indicating that 
homing might not be impaired in these animals.  
 
Closer inspection of FRCsΔTalin1 shows that a 3D network is still present, with FRCsΔTalin1 having 
enlarged rounded cell bodies (Figure 8G). YAP/TAZ expression in FRCsΔTalin1 is mainly restricted 
to the cytoplasm, with only little signal detected in the nucleus (Figure 8G). Furthermore, 
FRCsΔTalin1 appear somewhat functionally matured as given by their expression of ICAM-1 and 






Figure 8. Characterization of FRCΔTalin1mice. 
A, Organ weights compared between FRCsΔTalin1 and control mice. Images are of inguinal lymph nodes (LN). Scale 
bar = 1 mm. All  bars represent mean±SEM. B, CD3 and B220 staining on popliteal lymph nodes. C, Overview 
image of inguinal lymph node from FRC-mTmGΔTalin1 and FRC-mTmG mice stained for LYVE-1. Scale bars = 200 
µm. D, ERTR7 staining on popliteal lymph nodes from FRC-mTmGΔTalin1 and FRCs-mTmG mice. Scale bars = 20 
µm. E, PDPN and ERT7 staining on popliteal lymph nodes Scale bars = 200 µm. Zoom window taken from the 
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center area. Scale bars = 200 µm. F, HEV/T zone area. MECA-79 and CCL21 staining. Scale bars = 20 µm. G, 3D 
view of a 17um thick stack from the T-zone of from FRC-mTmGΔTalin1 and FRCs-mTmG mice. Stained for YAP/TAZ. 
Scale bars = 20 µm overview images, 5 µm zoom images. Quantification of N:C > 1. Mann-Whitney test (****, 
p<0.0001). H, ICAM-1, PDPN, VCAM and merged staining from T-zone area of popliteal lymph nodes. Scale bars 
= 20 µm. 
 
Together, these results indicate that FRCsΔTalin1 have a defect in mechanoperception. 
FRCsΔTalin1 lymph nodes have a severe phenotype that causes developmental defects in the 
formation of a proper extended T zone at the cost of enlarged medullary areas. It is 
conceivable these mice will have impaired immune responses. Though, the absence of an 
extended FRC network and impaired mechanoperception of FRCsΔTalin1 makes those mice an 
excellent tool to investigate the role of FRC tension in lymph node swelling. Thus, next we 
investigated how FRCsΔTalin1 lymph nodes swell upon immunization 
2.5.6 FRC mechanosensing via talin1 leads to increased tension on the FRC 
network in inflammation and limits the initial swelling rate of the lymph 
node 
To understand the role of FRC mechanosensing via Talin1 on lymph node swelling we first 
characterized the swelling rate of KLH/CFA inflamed lymph nodes from FRCΔTalin1 and control 
mice. Lymph nodes from FRCΔTalin1 mice are smaller than from control mice under homeostatic 
conditions, and after four and fourteen days of inflammation as measured by their weight, 
but this effect could not be properly measured by the less accurate volume calculations from 
2D side-images (Figure 9A,B). Initially, in the first four days of inflammation the swelling rate 
of FRCΔTalin1 lymph nodes was significantly faster than that of control lymph nodes, as 
measured by the ratio of weight increase (Figure 9C). However, the growth rate stagnated 
from D4 to D14 in FRCΔTalin1 mice while control lymph nodes kept increasing in size at a steady 
rate (Figure 9C). We next investigated if such altered swelling kinetics were reflected in the 
lymph node tissue properties of FRCΔTalin1 mice as measured by parallel plate compression 
experiments.  The effective resistances between FRCΔTalin1 and control lymph nodes derived 
from these experiment are comparable in homeostasis. However, in inflammation the 
effective resistance was significantly reduced in FRCΔTalin1 lymph nodes (Figure 9D). No obvious 
differences in elastic modulus and viscosity could be observed in any of the measured 
timepoints (Figure 9E,F). To understand what is the cause of the reduced effective resistance 
we turned to structural analysis of the FRCΔTalin1-conduit network and to UV-laser cutting 
tension measurements of the FRCΔTalin1 network (Figure 9G-K). After four days of inflammation 
conduits of FRCΔTalin1 mice show an impaired alignment of individual fibrils to the centerline 
of the conduit, indicating less tension on these structures (Figure 9G). No differences in fibril 
straightness could be observed (Figure 9I). In agreement with those results, the tension on 
the FRCΔTalin1 network was severely reduced as compared to the control FRC network (Figure 
9J,K). YAP/TAZ staining and quantification of FRCs strikingly show, like in the homeostatic 
situation, a complete absence of YAP/TAZ in FRCΔTalin1 nuclei at D4 of inflammation (Figure 9 
L,M). 
Together, these results show that mechanosensing by FRCs via Talin1 is required to increase 
tension on the FRC and conduit network in inflammation and limit the rate of lymph node 
swelling in the first days of inflammation. We next looked into how these altered forces and 
swelling dynamics affect the FRCΔTalin1 network. 
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Figure 9. FRC mechanosensing via Talin1 leads to increased tension on the FRC network in inflammation and 
limits the initial swelling rate of the lymph node. 
A-F, Tissue parameters derived from parallel plate compression experiments in homeostatic conditions and 
weight measurements between control and FRCsΔTalin1 popliteal lymph nodes at D0, D4 and D14 of inflammation. 
Unpaired t-tests (two-tailed). A, Volume as calculated from 2D side-views. B, Lymph node weight. C, Ratio 
increase of weight, based on data from B. D, Effective resistance. E, Elasticity. F, Viscosity. G, Representative 3D 
view of tracked fibrils from STEM tomography experiment at D4 inflammation of control and FRCsΔTalin1 mice. 
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Yellow line is conduit centerline, white l ines tracked fibrils. Blue is shadow-projection from obtained 3D stack. 
H-I, quantification of data from G. Each dot represents the average of a conduit. 7 -8 conduits are measured per 
conditions. Between 315 and 526 fibril  fragments were measured per condition. Data is from 2 experiments. 
n=2 animals. H, Fibril  alignment to conduit at D4 of inflammation. Mann-Whitney test (**, p=0.0059). I, Fibril  
straightness at D4 of inflammation. Mann-Whitney test (two-tailed) (ns, 0.3357). J, Representative examples 
from UV-laser cut experiments at D4 of inflammation between control and FRCsΔTalin1 mice. Scale bars = 5 µm. 
Scale bars kymograph: x-axis = 1 s, y-axis = 1 µm. K, Quantification of experiment in J. Each dot represents an 
individual cut cell. Data pooled from two experiments. n=3 animals. Unpaired t-test (two-tailed) (***, p=0.0007). 
L, Quantification of N:C YAP/TAZ intensity at D4 of inflammation. A cell  was measured as N:C > 1 or N:C < 1 and 
results are given as a boolean (yes: 1, or no: 2). Between 22 and 50 cells were measured. Data is from one 
experiment. n=1 animals. Mann-Whitney test (two-tailed) (****, p<0.0001). M, Representative images of 
experiment in L. Scale bars overview images = 20 µm. Scale bars zoomed images = 5 µm All  bars represent 
mean±SEM. 
2.5.7 The severity of FRCΔTalin1 network impairment increases in inflammation 
The FRCΔTalin1 network in the homeostatic situation is partly impaired (Figure 8), therefore  
the interpretation of FRCΔTalin1 network expansion in the swelling lymph node is challenging. 
However, the severity increases following inflammation. We investigated this using mGFP 
labeled FRCs and membrane tandem dimer tomato (mtdTomato) labeled non-FRCs in 
FRCΔTalin1 and control mice (Figure10A,B). FDCs are also targeted by the Cre-driver and show 
a more intense labeling than the other subsets found in the T zone, IF regions, and at the 
border of follicles. mtdTomato labeling is brighter in blood and lymphatic endothelial cells 
compared to lymphocytes, and structures can be further distinguished by morphology. 
Together, the differential labeling allows a good interpretation of the various micro-
anatomical regions of the lymph node (Figure 10). 
 
After four days of inflammation, wt control lymph nodes show an intact FRC network in which 
most of the area is occupied by the paracortex, and a cortex network that is properly 
connected to the SCS (Figure 10A). In contrast, no paracortical regions could be distinguished 
in FRCΔTalin1 lymph nodes at D4 of inflammation, and most of the area was occupied by 
lymphatic vessels and a loose FRCΔTalin1 network (Figure 10A). Furthermore, the FRCΔTalin1 
network also appeared to be poorly connected to the SCS (Figure 10A). No obvious 
differences in follicular regions could be detected between control and FRCΔTalin1 lymph nodes 
(Figure 10A). 
 
Two weeks after the onset of inflammation, the aberrations of the FRCΔTalin1 network 
increased. In the wt control situation, most of the network was still covered by a dense FRC 
network, while the FRCΔTalin1 network was poorly interconnected and showed large areas that 
were filled with lymphocytes, but were not covered by the FRCΔTalin1 network (Figure 10B). 
Some areas that resembled a paracortex were found in FRCΔTalin1 lymph nodes but they were 
only loosely interconnected as compared to the wt control situation (Figure 10B). In following 
timepoints, the cortex network was not properly attached to the SCS and showed regions that 
were either dense or sparsely populated by FRCs (Figure 10B). Follicular regions showed again 
no obvious defects (Figure 10B). Most FRC-covering areas resembled enlarged medullary 
cords with striking disorganization of FRCΔTalin1 network (Figure 10B).  
 
Together these results demonstrate that the FRC network is growing atypically in FRCΔTalin1 
mice and fails to form a proper interconnected FRC network, which is indicated by impaired 
interconnectivity, impaired attachment to the SCS, and failure to expand the T zone area. 
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Compared to the homeostatic conditions the FRCΔTalin1 network in inflammation is forming 
large areas that remain uncovered by FRCs. This indicates that talin1 is important for FRCs to 
construct a dense network that is well connected throughout the organ, and that Talin1 is 
important for T zone FRCs to extend the T zone in inflammation. 
 
 
Figure 10. Histological characterization of control FRC and FRCsΔTalin1 networks in inflammation.  
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A-B, Histological evaluation of the FRC network in FRC-mTmG (control) and FRCs-mTmGΔTalin1 mice after 4 and 
14 days of inflammation. FRCs are labeled by mGFP, while non-FRCs are labeled by mtdTomato. Arrowheads 
indicate FDCs, arrows TRCs. Scale bars overview images = 200 um, zoomed images = 20 um. A, Control FRC and 
FRCsΔTalin1 network at D4 of inflammation. B, Control FRC and FRCsΔTalin1 network at D14 of inflammation. 
2.5.8 The role of the capsule in in lymph node swelling 
The lymph node capsule is an understudied structure and knowledge about its physical 
properties or load bearing capacity in homeostasis and lymph node swelling is lacking. The 
capsule can be divided into two components: a floor that includes fLECs, and a roof that 
consists of extracellular matrix with embedded lymphoid fibroblasts onto which cLECs 
adhere. We further investigated the structural and physical properties of the two capsule 
components in homeostatic and inflammatory conditions. 
 
To study tension on fLECs we used the sparse labeling of LECs by CCL19-Cre mTmG mice. 
CCL19-Cre mice were originally developed and selected to primarily label mesenchymal 
stromal cells in lymphoid organs, however some LECs - that also express CCL19 – are 
additionally targeted by the Cre-driver156. Through histological analysis, we found that fLECs 
are sparsely labeled in CCL19-Cre GT26Sor mice. This was further demonstrated by their 
double positivity for mGFP and LYVE-1, and their location in the floor of the SCS (Figure 11A). 
Since the SCS floor is normally densely populated by fLECs, we used this sparse labeling to our 
advantage as it enabled the measurement of active tension on fLECs in vivo (Figure 11B-D). 
We found that fLECs had high levels of basal tension that exceeded those of FRCs. 
Interestingly, after two days of inflammation fLECs showed reduced tension (Figure 11E). As 
the lymph node is swelling significantly during this time, higher tension levels would be 
expected. The lowered tension levels thus indicate either an induced relaxation of fLECs or 
initial fast proliferation rates. During inflammation, fLEC tension levels went back to basal 
levels and remained constant, suggesting a steady expansion of the fLEC population to 
maintain basal tension levels during the further growth phase of the lymph node. Since fLECs 
were sparsely targeted by the CCL19-Cre driver, we asked how knocking out talin1 in fLECs 
and FRCs is affecting the tension levels of fLECs. After four days of inflammation we found no 
differences compared to wt control mice, arguing that FRC contractility and mechanosensing 
of fLECs via talin1 are not involved in regulating tension of the SCS floor. 
 
Next, we focused on the roof of the capsule. The capsule of explanted popliteal and inguinal 
lymph nodes was non-specifically labeled by Tetramethylrhodamin (TAMRA) staining. This 
resulted in labeling of the capsule extracellular matrix, which showed an anisotropic layered 
organization of collagen bundles that represented the organization of the capsule accurately 
as compared to STEM and scanning electron microscopy (SEM) images of the capsule (Figure 
12A,B). Using a high-power UV-laser, cuts were made in the extracellular matrix and the active 
tension on those structures was measured by determining the recoil velocities using particle 
image velocimetry (PIV) (Figure 12A). PIV was applied on the pre-cut and first post-cut frame 
to measure the average displacement of structures above and below the cut. We found that 
tension in the capsule was slightly increased in the first four days of inflammation, and 
subsequently dropped again to homeostatic conditions when the lymph node size reached its 
maximum volume (Figure 12C). These results suggest that the capsule is being actively 
remodeled when the lymph node swells, since the large surface area increase of the capsule 
would otherwise result in a much larger tension increase. This indicates that lymph node 
swelling rate is slightly faster than the remodeling process, and therefore results in a slight 
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increase in active tension. Following D4 of inflammation, active tension on the capsule is 
declining, indicating that the active remodeling capacity of the capsule is succeeding the 
lymph node swelling rate. 
 
 
Figure 11. Capsule tension of the floor compartment in inflammation.  
A, CCL19-Cre GT26Sor mice sparsely label fLECs of the SCS. B, Overview of the UV-laser cut experiment on fLECs 
tension measured in surgical exposed inguinal lymph nodes from CCL19-Cre GT26Sor mice. Arrows indicate 
location of cut and recoil  of fLEC. Dashed lines indicate axis along which kymographs are typically created. Scale 
bars = 20 µm. C, Representative examples of fLEC UV-laser cuts at homeostasis and various timepoints after 
inflammation. Arrows indicate location of cut and recoil  of fLEC .Scale bars = 10 µm. D, Kymographs from 
respective examples from C. Dashed lines indicate the slopes that were used to measure recoil  velocities. Scale 
bar x-axis = 1s, scale bar y-axis = 2 µm. E, Quantification of recoil  velocities of fLECs in homeostasis and 
inflammation. Each dot represents an individual cut. Between x and x cuts per timepoint were measured. Data 
is pooled from 2 experiments. n=3 animals per timepoint. Kruskal Wallis test (Chi square = 23.66, df = 4, ****, 
p<0.0001), Dunn’s post-hoc test. F, Quantification of recoil  velocities of fLECs in control and CCL19-Cre Talin1fl 
mice after four days of inflammation. Data is pooled from 2 experiments, n=3 animals per condition. Unpaired 




To better understand the remodeling of the capsule, we analyzed the capsule by histology in 
Prospero homeobox protein 1 (Prox1)-green fluorescent protein (GFP) mice in which the 
cytoplasm of all LECs is labeled with GFP. Additional platelet-derived growth factor receptor- 
β (PDGFR-β) and 4′,6-diamidino-2-phenylindole (DAPI) staining allowed the measurement of 
capsule thickness and mesenchymal cell layers of the capsule above the SCS in homeostasis 
and inflammation (Figure 12D). We found that the capsule thickness remained similar in the 
first four days of inflammation, with one to two cell layer thick structures. Strikingly, the 
capsule thickness increased ~14-fold from D8 to D14 of inflammation, creating a significant 
fibrotic layer between the parenchyma and surrounding adipose and muscle tissue, while the 
SCS remained intact (Figure 12D,E).  
 
We asked if such significant remodeling of the capsule resulted in changes in local mechanical 
properties of the capsule. To derive its elastic property, we deployed a micro-pipette with a 
small diameter and locally aspirated ERTR7 labeled capsules of popliteal lymph node explants. 
We measured the height of the aspirated ‘tongue’, then used these measurements in 
combination with the known pipette diameter and pressure difference between the pipette 
and atmosphere to derive the elasticity of the capsule, using Laplace’s law (Figure 12F). We 
found that the elastic modulus of the capsule remains stable over the first eight days of 
inflammation and increased significantly at D14 (Figure 12G). By multiplying the capsule 
thickness and elastic modulus of the capsule, we derived the passive capsule tension, which 
is a measure of the amount of force necessary to enlarge the whole thickness of the capsule 
by a certain length (Figure 12H). The passive tension should not be confused with active 
tension, which describes the energy stored on a structure that is generated via an external 
force. 
 
We further asked if tension on the FRC network had any effects on the capsule dynamics as 
described above. We therefore measured capsule tension at in FRCΔTalin1 and wt control mice 
and found no differences, suggesting FRC contractility is not affecting capsule tension (Figure 
12I). Further, capsule thickness was comparable between FRCΔTalin1 and control mice at D14 
of inflammation (Figure 12J). 
 
Together, these experiments show that the capsule is undergoing a complex dynamics in 
which remodeling and tension are balanced in the growing organ to maintain integrity of the 
extracellular matrix component network and SCS. These results further indicate a differential 
role for the floor and roof of the SCS, in which the roof is providing the most resistance to 
organ swelling while the floor stores the most active tension. This implies that the capsule 
roof is expected to have a role in limiting organ growth via a larger resistance to swelling, 
while the floor of the SCS is always under high active tension and could be important in 




Figure 12. Capsule tension and remodeling of the roof compartment in inflammation. 
A, Overview of the UV-laser cut experiment on TAMRA labeled extracellular matrix of the capsule on explanted 
lymph nodes. PIV was used to measure displacement of structures above and below the cut site, indicated by 
orange vectors. Scale bar = 20 µm. B, Capsule imaged in STEM and SEM. Scale bars = 1 and 5 µm, respectively. 
C, Quantification of recoil velocities of capsule cuts. Between 7 and 25 cuts were taken per timepoint from at 
least 5 lymph nodes. n=2 animals per timepoint. Kruskal Wallis test (Chi square = 14.51, df = 4, **, p=0.0058), 
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Dunn’s post-hoc test. D, Histological representative examples of capsules of Prox1-GFP mice at homeostasis and 
different timepoints in inflammation, used to measure thickness of the capsule. Scale bars zoomed images = 20 
µm, scale bars overview images = 200 µm. E, Quantification of capsule thickness in homeostasis and 
inflammation. Thickness was measured on 3-5 popliteal lymph nodes per timepoint from 2 experiments. n=2-3 
animals per timepoint. Kruskal Wallis test (Chi square = 14.56, df = 5, **, p=0.0057), Dunn’s post-hoc test. F, 
Overview and representative example of micro-pipette assay. Local elasticity of the capsule is derived using the 
Laplace law. Kruskal Wallis test (Chi square = 12.81, df = 4, *, p=0.0123), Dunn’s post-hoc test. G, Quantification 
of micro-pipette assay. Between 2 and 7 popliteal lymph nodes per timepoint were used for measurements, 3-
5 measurements were averaged per lymph node. Data is derived from at least 2 experiments, n=3-4 animals per 
timepoint. Kruskal Wallis test (Chi square = 19.43, df = 4, ***, p=0.0006), Dunn’s post-hoc test H, Passive tension 
on the capsule derived from thickness measurements and local elasticity measurements. Kruskal Wallis test (Chi 
square = 19.43, df = 5, ***, p=0.0006), Dunn’s post-hoc test. I, Capsule thickness at D14 of inflammation between 
popliteal lymph nodes of FRCsΔTalin1 and control mice. Each dot represents a lymph node. Between 3-5 lymph 
nodes were measured. n=2-3 animals per condition. Mann-Whitney test (two-tailed) (ns, 0.5714). J, Capsule 
tension of the roof as measured by UV-laser cut of TAMRA labeled capsules. Data pooled from 4 to 5 lymph 
nodes per condition. n=2-3 animals from 1 experiment. Mann-Whitney test (two-tailed) (ns, 0.0546). All  bars 
represent mean±SEM. 
2.5.9 FRC expansion following inflammation 
It is well established that the FRC network is expanding in inflammation and some studies 
have looked at the spacing or expansion of the FRC network in the swollen lymph node 186,187. 
However, spatio-temporal dynamics of the FRC network spacing and FRC proliferation in the 
expanding 3D network of the swelling lymph node has not been fully addressed. Therefore, 
we analyzed the FRC network following inflammation and quantified the spacing (gaps) of the 
network in the T zone at different timepoint of inflammation (Figure 13). To this end, a circle-
fitting algorithm was used to characterize the distribution of gaps found in homeostatic and 
inflamed lymph nodes (Figure 13A). No disruption of the network and no difference in 
network gaps was observed at any measured timepoints after inflammation, suggesting the 
network is actively adapting to the volumetric needs imposed by the swelling lymph node 
(Figure 13B-D).  
 
Next, we investigated how the FRC network is spatio-temporally expanding in the inflamed 
lymph node by making use of a sparse clonal labeling approach: Mosaic Analysis with Double 
Markers (MADM) 222 (Figures 14,15). MADM depends on rare interchromosomal mitotic 
recombination events driven by Cre-loxP sites. Two reciprocally incomplete GFP and 
tdTomato genes (GT and TG) on identical loci of homologous chromosomes of mice are used 
to create offspring that are transheterozygotes (GT/TG) (Figure 14A). No functional 
fluorescent proteins are transcribed in absence of recombination. However, when rare 
interchromosomal recombination events take place in the G2 phase of the cell cycle, 
functional GFP and tdTomato expression cassettes are restored (Figure 14B). When followed 
by X-segregation of chromosomes in mitosis, two daughter cells are formed in which one 
expresses GFP (green lineage) and the other tdTomato (red lineage). Alternatively, Z-
segregation and recombination in G1/G0 phases of the cell cycle can also lead to the formation 
of cells that expresses both functional cassettes (yellow lineage). This implicates that cells - 
although rare - can become yellow over time. Therefore the system allows the cleanest 




Figure 13. FRC network GAP analysis in inflammation.  
A, Overview or workflow for FRC network GAP analysis. B, Representative examples of circle fitting algorithm. 
C, Distribution of circle radii  fitted in between the FRC network weighted for the area fraction occupied. Curves 
were smoothed by a second-order polynomal. Kruskal-Wallis test (Chi square = 4.421 (df =4, ns, p=0.3520). D, 
FRC network GAP distribution. Large GAP sizes were compared via the area under the curve (AOC) from a circle 
radius of 12 µm. Data from 5 lymph nodes from at least 2 different experiments. About 10 image stacks between 
10-30 µm depth were acquired with a 40x objective and used for the analysis. Kruskal-Wallis test (Chi square = 




Compared to most other labeling systems based on Cre-loxP-mediated labeling, MADM labels 
cells sparsely, what enables to follow individual clones with more precision. Labeling 
efficiency highly depends on the Cre-driver and the chromosome into which is the MADM 
cassette inserted. To this end we generated experimental mice by breeding CCL19-Cre hem; 
MADM-7GT/GT with CCL19-Cre hem; MADM-7TG/TG mice to obtain CCL19-Cre hem; MADM-
7GT/TG mice that have the MADM cassette on the 7th chromosome (MADM-7), which was 
expected to generate a decent labeling efficiency223 (Figure 14A). Indeed, experimental mice 
showed sparse labeling of FRCs in homeostatic lymph nodes (Figure 14C). In theory, when 
labeling is sparse, division patterns of red and green clones can be assessed (Figure 14D). We 
assumed that upon FRC proliferation, cells would not migrate substantially and form clonal 
clusters. Therefore, we expected that FRC clusters, and symmetric and asymmetric division 
pattern of individual FRC clones can be distinguished in inflammation (Figure 14E). 
 
Experimental MADM mice were immunized by footpad injections of KLH/CFA and draining 
popliteal lymph nodes were harvested after four or eight days of inflammation, and in 
addition homeostatic popliteal lymph nodes of experimental MADM mice were taken. All 
mice were intravenously (i.v.) injected with fluorescently conjugated MECA-79 antibody to 
label HEVs before being sacrificed (Figure 14F). To obtain a holistic view of FRC expansion, 
whole lymph nodes were cleared and subsequently imaged by lightsheet microscopy (Figure 
14G). After reconstruction, green, red and yellow FRC lineages were labeled in 3D, and only 
green and red lineages were further used for analysis (Figure 14H). 
 
Next, the clustering of red and green lineages was quantified to address when and where 
FRCs were expanding after inflammation. The cluster analysis was complicated by the fact 
that the number of labeled cells as well as the lymph node volume varied between conditions. 
Likewise, common clustering algorithms require prior knowledge about either the cluster size 
or the inter-cluster distance, which we were unable to extract. Application of such algorithms 
was further complicated by the fact that lymph nodes cannot be followed over time. Hence, 
the following approach was chosen: the average distance to the next n FRCs (neighbors) was 
calculated for each cell and compared to the same measure of in silico randomly distributed 
cells (same number of cells and volume). The cluster factor (CF) was then calculated as the 
ratio of the average distances to the next n neighbors of the observed FRC distributions (for 
both the red and green lineage) to those of the random distributions (Figure 14I). In order to 
avoid edge effects, FRCs in a region from the surface of the lymph node were excluded (D0: 
100 µm, D4: 200 µm, D8: 400 µm, respectively). The CF is a function of the number of 
neighbors (Figure 14I). Further analysis was performed for five neighbors, since the final result 
only weakly depends on the number of neighbors, and five neighbors (a cluster size of six 
FRCs) was thought to be a reasonable, conservative assumption of the expected cluster size 
at inflammation timepoints (Figure 14I). Furthermore, we set the cut-off of a non-clustered 
cell at a CF of 1.175 or below, based on a conservative interpretation of the homeostatic 
baseline of CF values (Figure 14I). 
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Figure 14. Principles of Mosaic Analysis with Double Markers (MADM) and analysis.  
A, Breeding overview. CCL19-Cre hem; MADM-7GT/GT male mice were crossed with CCL19-Cre hem; MADM-7TG/TG  
female mice to obtain experimental CCL19-Cre hem; MADM-7GT/TG mice. B, MADM principle. Rare 
interchromosomal recombination in G2 cell  cycle phase following x-segregation of chromosomes can lead to 
either red or green FRC labeling. C, Sparse labeling of FRCs with GFP or tdTomato (or both). Scale bar = 200 µm 
D-E, Tracking MADM clones. Red and green circles represent GFP+ and tdTomato+ FRCs, respectively. D, Division 
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pattern can be followed to distinguish between symmetric or asymmetric division of expanding clones. E, 
Hypothetical i l lustration of how symmetric and asymmetric clones of FRCs might look l ike following 
inflammation. F, Experimental overview. Popliteal lymph nodes are taken from in homeostatic conditions or 
following 4 or 7 days of inflammation and fixed. HEVs were labeled by i.v. injection of MECA79-Atto647N 10 
minutes before sacrificing. G, Il lustration of lymph node clearing and imaging by l ightsheet microscopy. H, 
Schematic of 3D annotation of GFP+ (green) and tdTomato+ (red) FRCs. Double labeled cells are ignored. I, 
Schematic representation of the cluster analysis in 2D (actual analysis performed in 3D). The observed FRC 
distribution is compared to an in silico distribution of the same number of cells in the same volume. The average 
distance of each cell  to n nearest neighbors was computed for the observed and random distribution, and 
divided by each other to obtain a cluster factor (CF). The CF therefore depends on the number of neighbors. All  
further analysis is performed for 5 neighbors (vertical dashed line). A CF of 1.175 (dashed horizontal l ine) was 
taken as a conservative baseline of D0 values to distinguish clustered vs non-clustered FRCs (CF<1.175). 
 
3D Reconstruction of light-sheet images showed an effective labeling of the HEV network, 
and dense labeling of FRCs after inflammation, which was accurately mapped in 3D (Figure 
15A). The cluster factor increased significantly in inflammation, as represented in sliced views 
of center region of lymph nodes in which the CF is annotated by an alpha-value (Figure 15B). 
Red and green clusters appeared to be randomly spread throughout the lymph node and not 
to be specifically associated with HEVs, suggesting that FRCs were proliferating at random 
throughout the lymph node instead of at select anatomical compartments (Figure 15B). To 
further illustrate the spread of red and green FRC clusters throughout the lymph node, CF’s 
were blurred in 3D and overlaid on the lymph node and HEV network volume, illustrating the 
formation of more distinct clusters over time in inflammation timepoints (Figure 15C).  
 
Further quantification of the data showed that lymph nodes were effectively growing from 
D0 to D4 and D8 of inflammation (Figure 15D). The reconstructed HEV network volume did 
not increase significantly, likely the result of labeling quality and subsequent consistent 
volume generation (Figure 15E). Labeling efficiencies in homeostatic lymph nodes were in the 
order of hundreds per lymph node, and the number of labeled cells increased to the order of 
thousands at inflammatory timepoints (Figure 15F).  
 
We found a small bias towards red cells in homeostatic lymph nodes, but no significant bias 
in labeling at later timepoints, indicating a small heterogeneity in labeling (Figure 15F,G). 
Since no obvious bias towards one labeling was observed, we performed all further analyses 
on the combined clusters of red and green lineages, weighted for the number of labeled cells.  
 
Our cluster analysis shows that many individual FRCs are proliferating upon inflammation, 
and that FRCs become more clustered over time, indicating FRCs were proliferating in a clonal 
manner. Both, the ratio of clustered to non-clustered FRCs, and the average cluster factor 
were increased between homeostatic and inflammatory timepoints, suggesting progressively 
more FRCs were clonally expanding (Figure 15H,I).  
 
It has been previously suggested that de novo stromal cells in the developing and adult spleen 
can arrive from ubiquitous perivascular areas74,224,225. We therefore investigated whether 
perivascular precursors are a main source of newly formed FRCs in the inflamed lymph node. 
To this end, the average distance of a clustered FRCs to the nearest HEV, and the average 
cluster factor as a function of the distance from the nearest HEV, was plotted (Figure 15J,K). 
We found that the average distance of a clustered FRC to the nearest HEV was increased from 
around 45 µm in homeostasis, to 68 µm and 91 µm, at D4 and D8, respectively (Figure 15J). 
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Although more clustered FRCs were found around HEVs during inflammation, no 
accumulation at perivascular sites was observed (Figure 15K).  
 
Interestingly, the proliferation of FRCs, and therefore the observed increase in CF during 
inflammation, correlates well with the lymph node volume, suggesting that the proliferation 
of FRCs is adapting to swelling rate of the lymph node, or vice-versa dictates the swelling rate 
of the lymph node (Figure 15L).  
 
Together, these results show that that during the swelling of the lymph nodes the FRC 
network remains intact. The recombining of MADM cassettes on chromosome 7 driven by the 
CCL19-Cre efficiently labeled FRCs in lymph nodes. While high labeling densities of FRCs in 
inflammation timepoints prevented us from making conclusions on the mode of clonal 
expansion, it allowed us to analyze to which extent FRCs are clustering and where such 
clustering takes place. We found that expansion of the FRC network is the direct result of local 
FRC proliferation that forms clusters dispersed throughout the lymph node without any bias 







Figure 15. MADM analysis of homeostatic and inflamed lymph nodes.  
A, Overview of the labeling of HEVs and tdTomato cells at D4 of inflammation. The most right image shows a 
cluster of FRCs and the gray sphere on each cell  body represents how the cells were mapped in 3D. B, Cluster 
factor shown for GFP+ (green) and tdTomato+ (red) FRCs (represented as dots) in a 150 µm thick sl ice of 
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homeostatic and D4 and D8 inflammation timepoints. Cluster factor was mapped as an alpha value. Blue dots 
represent non clustered cells. Graph ticks are given in µm. C, Clusters represented as blurred clouds. Red and 
green blurs represent areas of clustered tdTomato+ and GFP+ FRCs, respectively. Gray structures are HEVs. Scale 
bars = 300 µm. D-K, Quantification of l ightsheet imaged lymph nodes. GFP+ FRC = green, tdTomato+ FRC = red. 
Each dot represent a lymph node. n=5 per timepoint. Data obtained from 2 individual experiments. All  bars 
represent mean±SEM. D, Lymph node volume. Welch ANOVA (Chi square = 107.3 (2, 5.490), ****, p<0.0001), 
Dunnett’s post-hoc test E, HEV volume. Kruskal Wallis test (Chi square = 4.940, df = 2, ns, p=0.0807), Dunn’s 
post-hoc test. F, Labeling distribution of MADM labeled FRCs. Mann-Whitney test (two-tailed): D0(**, p=0.0079), 
D4(ns, p=0.3095), D8(ns, p=0.6905). G, Relative MADM labeled FRC distribution. Kruskal Wallis test (Chi square 
= 10.50, df = 2, ***, p=0.004), Dunn’s post-hoc test. H, Ratio of clustered vs. non-clustered FRCs for green, red, 
and green+red (weighted for the number of labeled cells) FRCs. One-way ANOVA (F=28.09, df=2, R2=0.8240, 
****, p<0.0001). Tukey post-hoc test. I, Average cluster factor (for 5 neighbors), for green, red, and green+red 
FRCs (weighted for the number of labeled cells). One-way ANOVA (F=37.06, df=2, R2=0.8607, ****, p<0.0001). 
Tukey post-hoc test. J, Average distance of clustered FRCs (for 5 neighbors) to the nearest HEV. Given for green, 
red, and green+red (weighted for the number of labeled cells) MADM labeled FRCs. One-way ANOVA (F=41.86, 
df=2, R2=0.8746, ****, p<0.0001) Tukey post-hoc test. K, Average cluster factor red+green FRCs (for 5 neighbors) 
as a function of the distance from the closest HEV. L, Correlation between lymph node (LN) size and cluster 







In this study we investigated how the lymph node is able to swell in a coordinated manner 
upon immunization by KLH/CFA, which induces a fast and extensive long-term swelling. The 
rapid swelling imposes an internal structural problem as the dense FRC network has to cope 
with a volumetric increase and timely adapt to these challenges, risking physical ripping of 
the network and being functionally underdeveloped, with catastrophic implications for the 
immune response86,88,89. We show that the FRC network does remain intact. Using the MADM 
sparse labeling approach we demonstrate that FRCs are proliferating and clustering in the 
swollen lymph node in a spatially unbiased manner that correlates with the lymph node size. 
We were not able to characterize the clonal nature of FRC proliferation, for which sparser 
labeling is required. Future experiments would allow sparser labeling by positioning the 
MADM cassette on a different chromosome. Furthermore, these results suggest a generic 
mechanism that drives FRCs proliferation in an unbiased manner over a model in which FRC 
expansion is regulated in microanatomical niches. The correlation between lymph node size 
and cluster factor further indicates a feedback mechanism between FRC proliferation and 
lymph node size. 
It has been previously shown that FRC proliferation can be triggered by increasing the lymph 
node lymphocyte cellularity in absence of any inflammatory signals, and a mechanical 
feedback mechanism has been suggested186. This implies that if a mechanical feedback loop 
between lymph node size and the stromal backbone expansion exists, it is likely regulated by 
lymphocyte cellularity. Lymphocyte numbers directly dictate the size of the lymph node and 
therefore an understanding of how lymphocytes are physically able to enter an organ that is 
fully packed, while the lymph node is remaining at a stable size under homeostatic conditions, 
is crucial in recognizing how the lymph node is able to swell. Studying the swelling of the 
lymph node therefore requires a detailed understanding of how forces on the organ are 
dynamically changing in the reactive lymph node and how they relate to lymph node 
cellularity in both homeostatic and inflammatory conditions. This was achieved by 
characterizing the tension on the extracellular matrix, FRC network and capsule components  
using parallel plate compression, UV-laser cutting and micropipette experiments. By 
manipulation of lymph node cellularity in homeostatic conditions we could show a direct link 
between cellularity and mechanical/physical properties of the lymph node, as measured by 
parallel plate compression experiments. We further show that in the reactive lymph node, 
the tension on the FRC network and capsule are drastically changed in a complex dynamic 
compared to the homeostatic situation (Figure 16A). Furthermore, at the endpoint of 
swelling, two weeks after the onset of immunization, the lymph node reaches a new tension 
equilibrium. I will first discuss results in this study before moving to a model of how a 
mechanical feedback loop between lymphocyte cellularity and tension on the stromal 
backbone of the lymph node could be involved in keeping the lymph node size stable in 
homeostatic conditions and allow it to swell in inflammation. 
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It has been established that increased lymphocyte cellularity in the lymph node is dictating 
size of the organ. Using parallel plate compression experiments we were able to measure the 
effective resistance of the tissue to swelling and showed that lymphocyte cellularity directly 
dictates the effective resistance in both homeostatic and reactive lymph nodes. This 
parameter is a useful measurement as it directly shows the force necessary to enlarge the 
lymph node by a given radius. We investigated if such resistance to growth could be the result 
from the FRC and conduit network, and found that the conduit extracellular matrix becomes 
more stretched following immunization by KLH/CFA. Furthermore, the tension on the FRC 
network is increasing between day two and four after onset of inflammation and remains high 
during the further growth phase. This is in agreement with a previous finding which shows 
that alpha smooth muscle actin (αSMA) expression in FRCs, an indication of contractility, 
increases later in inflammation186. In our experimental setup, we were limited to measuring 
FRC network tension by UV-laser cutting at the cortical network. Nevertheless, we believe it 
is a good representation of the whole organ, as lymphocytes are not limited to local tension 
induction. In addition, FRC N:C YAP/TAZ ratios and conduit extracellular matrix alignment 
experiments from (deep) paracortical lymph node structures showed a similar dynamic to the 
FRC tension measurements. We argue that increased straining of the conduit extracellular 
matrix results in higher substrate rigidity via non-linear strain-stiffening, which in turn can 
create a positive feedback loop with FRCs and results in enhanced contractility226. 
Interestingly, we found that FRC tension is delayed from conduit alignment. This delay could 
be explained by a mechanism in which the FRC network is actively relaxed. DCs have the 
ability to relax the FRC network, and migratory DC numbers are peaking around day two of 
inflammation and drop significantly four days after onset186-188. This could give the lymph 
node a certain flexibility to cope with the rapid size increase and explain the observed delay 
in FRC tension. Alternatively, it is possible that a threshold for conduit stretching to which 
FRCs react is not reached at day two of inflammation, although our experiments do not 
indicate a further alignment of the conduit network from day two to day four of inflammation. 
Furthermore, fLECs (that also express PDPN and are in contact with DCs) are under less 
tension at day 2 of inflammation, while tension on the extracellular matrix of the capsule is 
increasing. Therefore, a mechanism involving active relaxation seems the most reasonable.  
We further investigated the role of FRC contractility on lymph node swelling. FRCΔTalin1 mice 
have FRCs that are unable to perceive the increase in tension and fail to increase contractility 
subsequently. This was indicated by their round morphology and low N:C YAP/TAZ ratios, and 
further demonstrated by their reduced recoil velocities in inflammation by in vivo UV-laser 
cutting experiments. Using these mice, we show that tension of the FRC network is important 
to limit the swelling rate of the lymph node, as FRCΔTalin1 mice in which FRC tension is not 
increased in inflammatory timepoints show faster swelling rates the first four days of 
inflammation. Importantly, the swelling of the organ should also be balanced by expansion of 
the FRC network and this has been shown to be tightly regulated since FRC and lymphocyte 
compartment sizes remain stable during inflammation186. Our experiments show that failure 
of FRCsΔTalin1 to increase tension in inflammation and subsequent faster lymph node swelling 
dynamics are correlated with impaired expansion of the FRC network, as evidenced by a 
loosely connected network containing large lymphocyte-filled areas that are not covered by 
the FRC network. FRCΔTalin1 mice already have an impaired FRC network in homeostasis, 
showing a role of FRC mechanosensing in the formation and maintenance of a proper T zone. 
It was not possible to conclusively determine to which extent the observed network defects 
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in inflammation are the result of the initial impaired network or the initial increased swelling 
rate. However, severity of the FRC network impairment appears to increase during 
inflammation, arguing for a further dysregulation of the FRC and lymphocyte compartment 
size. Experiments that directly detail the FRC and lymphocyte compartment sizes in 
inflammation in these mice should further elucidate if FRC mechanosensing has a role in 
regulating the FRC and lymphocyte population size ratios in the swelling lymph node. 
Importantly, we found that reduced FRC contractility in inflammation results in a lower 
effective resistance as measured by parallel plate compression experiments. The most 
conservative interpretation of these results is that FRC contractility in inflammation increases 
the resistance to swelling and limits the initial lymph node swelling rate by dictating how 
many lymphocytes are able to enter the organ. 
FRC mechanosensing of tension and consequent contractility might have additional roles. 
High levels of mechanical signaling on inherently contractile cells such as fibroblasts and 
vascular smooth muscle cells leads to proliferation and extracellular matrix production220. It 
is conceivable that FRCsΔTalin1 have impaired YAP/TAZ signaling as indicated by low N:C ratios, 
and that therefore such underlying pathways could be important for the formation of an 
intact T zone network in both development and homeostasis, both of which are impaired in 
FRCsΔTalin1 mice. General FRC proliferation does not appear to be affected in FRCsΔTalin1 mice 
following immunization, indicating other mechanisms than mechanosensing-driven 
proliferation are important for FRC expansion. Another function for FRC 
mechanosensing/contractility involves adhesion to the conduit substrate, which has been 
shown to be crucial for FRC survival in late inflammatory conditions, but not in 
homeostasis206. The differential effect between these two situations could be explained by 
our results showing increased tension on FRCs later in inflammation, which may render FRCs 
more susceptible to anoikis. Furthermore, mechanosensing by FRCs might be important for 
expression of homeostatic chemokines, of which a detailed understanding of the regulation 
of expression is missing, as FRCsΔTalin1 do not express CCL21227. 
Importantly, the increase in FRC tension is transient and when the maximum size of the 
swelling lymph node is reached after two weeks of onset of inflammation, tension levels of 
the FRC network are reduced to homeostatic levels. Interestingly, we found that a slight drop 
in FRC tension around D8 of inflammation coincides with remodeling of the capsule. Between 
D8 and D14 of inflammation the capsule increases its size a striking ∼14-fold, together with 
an increase in elasticity. This results in a high passive tension, which implicates that high 
forces are needed to deform it. These results indicate that after D8 of inflammation the 
tension on the FRC network is gradually shifted towards the capsule. The thick solid capsule 
is likely to limit any further growth of the organ, bringing the whole system into a new force 
equilibrium that allows FRCs to return to homeostatic levels. Counter-intuitively, we could 
not see a significant increase in effective resistance at D14 of inflammation using parallel plate 
compression experiments, although values are slightly higher than in previous inflammation 
timepoints. This could be the result of cleaning the lymph nodes from adipose tissue and 
thereby partly disrupting the capsule, what is possible to happen during the procedure, and 
requires further attention. Furthermore, we observed a reduction of the adipose tissue 
surrounding the popliteal lymph node following inflammation. It is conceivable that such 
tissues are a viable source of energy that plays a role in supporting the swelling of the lymph 
node. 
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After the peak of inflammation, lymph nodes slowly contract to their original size over the 
course of weeks or months, depending on the stimulus given186,203. Contractile forces are 
necessary to facilitate such volumetric contractions. Our experiments suggest a role for fLECs 
as they are consistently found to be under high active tension and their localization in the SCS 
is suitable for concentric contractions. Secondary immunological challenges in a previously 
swollen lymph node interestingly result in a lower swelling capacity compared to the initial 
response203. It would be therefore interesting to address if those lower swelling capacities 
can be related to a persistently thickened capsule. 
The experiments in this study allow us to conclude with a hypothetical model of how lymph 
node size is regulated in homeostasis and inflammation (Figure 16B). Since lymphocytes are 
constantly entering the lymph node, it is easy to imagine a relationship between lymphocyte 
homing rates and resistance of the organ to swelling. Although there are fluctuations in 
homeostatic lymph node size due to circadian homing dynamics of both cell intrinsic 
properties and external factors, the lymph node size remains remarkably stable175. It is 
unknown how exactly this balance is achieved as either or both the influx and efflux of 
recirculating lymphocytes should be regulated in a fully packed organ where there is no free 
space available. Immune cells have been proposed to have intrinsic capacity to sense if there 
is space inside the lymph node, and are only able to enter once another lymphocyte exits the 
organ124. Lymphocyte entry (HEVs) and exit points (cortical and medullary sinuses) are to 
some extent spatially organized in close proximity to each other, which could explain these 
dynamics. However, vast lengths of HEVs are expected to be at significant distances from 
these exit points. It is therefore unclear how such space-sensing would work on long ranges. 
Our finding that blocking the exit of lymphocytes does not result in swelling of the organ 
indicates that the lymphocyte cellularity in the organ might be capped by external effectors, 
such as the effective resistance. Since we show that the effective resistance directly depends 
on lymphocyte numbers, we envision a scenario in which lymphocytes have to produce a 
minimal force to enter into the parenchyma. When cellularity and therefore the effective 
resistance is increasing under homeostatic conditions, lymphocytes fail to generate the force 
necessary to enter the organ and are sequestered in HEVs. The amount of force a lymphocyte 
can generate is likely not only an intrinsic property, since external factors such as chemokines 
also have an effect on lymph node size175. This could potentially explain that lymphocytes are 
still able to enter the organ under inflammatory conditions when the effective resistance is 
increasing.  
A calculation teaches us that if a spherical lymph node with a diameter of 1mm ought to be 
expanded by a radius of ~1 cell length or 2.5 µm (a lymph node volume increase of 7*106 
µm3), about 108*103 lymphocytes with a volume of 65 µm3 each need to enter, considering 
no lymphocyte is exiting the lymph node. The typical effective resistance we measured is 
about 0.2 µN/µm (0.5 µN for a 2.5 µm radius increase), therefore on average each cell has to 
overcome a force of 4.6 pN, which is much lower than the force a lymphocyte can generate228. 
However, the force necessary to enter is likely not linear, and increase of cellularity could 
have non-linear effects on the effective resistance. For instance, the forces on the FRC 
network could scale differently than the volume. This could mean that initially, cells are able 
to enter the lymph node, but further increase in size would require higher and higher forces, 
leading to an equilibrium state in which the size remains stable. In the swelling lymph node, 
we envision a scenario where the expansion of lymph node stroma is constantly lowering the 
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tension on the FRC network and thereby lowers the effective resistance, allowing more cells 
to enter. This would imply that the swelling of the lymph node is a dynamic event between 
lymphocytes entering and growth of the stromal backbone, in which a dynamic equilibrium is 
constantly reached. This could also explain the tight regulation between the lymphocyte and 
FRC compartment size. Additionally, we observed smaller lymph node sizes in situations 
without cognate T cells present, this suggest that proliferating lymphocytes within the organ 
produce additional tension in the lymph node. Such extra source of tension generation on the 
stromal backbone could enhance FRC proliferation, allowing even faster growth rates of the 
stroma that would reduce tension on the network, lower the effective resistance, and allow 
more lymphocytes to enter to organ. This suggestive mechanism is hard to validate with 
biological experiments alone, and simulations could provide additional support and make 
predictions that could be tested. Some further support for effective resistance as the key 
regulator in lymphocyte homing comes from our experiments and work from others. Our own 
experiments in which FRCΔTalin1 mice have a lower effective resistance, show an increased, 
and uncoordinated, lymph node swelling rate (Figure 16C). This effect was abolished in the 
later swelling phase and could be the result of an impaired FRC network that is required to 
maintain viability of T cells93. Further support comes from experiments in which DCs that are 
unable to relax FRCs induce impaired lymph node swelling, possibly by failing to lower the 
effective resistance187. In line with this hypothesis, lymphocytes that have reduced capacity 
to generate force also have homing impairments229-231. Such a mechanism of lymph node 
cellularity control might be important in homeostasis to prevent excessive stromal cell 
proliferation upon cellularity fluctuations during the day, as is the case when cellularity is 
increased significantly186. Interestingly, in homeostatic conditions where lymph node 
cellularity follows a circadian rhythm, an influx of DCs is observed before lymphocyte 
cellularity is increased, which could lower the effective resistance by relaxing FRCs and allow 
more lymphocytes to enter175,187. Further experiments involving artificial manipulation of the 
lymph node effective resistance and lymphocyte force generating factors and their effect on 
lymphocyte homing have the potential to shine more light on the role of effective resistance 
in regulating lymphocyte homing and the lymph node size. 
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Figure 16. Hypothetical model of lymph node swelling. 
A-C, Dynamics of effective resistance and lymphocyte cellularity are exaggerated to i l lustrate their relation, 
time-lengths of such interplay between events are unknown, but are l ikely to be more frequent. A, Overview 
of tension on various anatomical compartments and size increase. B, Relation between lymph node size, 
effective resistance and lymphocyte cellularity in control mice. C, Relation between lymph node size, effective 
resistance and lymphocyte cellularity in FRCΔTalin1 mice. 
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2.7 Materials and Methods 
Animals 
All animal experiments are in accordance with the Austrian law for animal experiments. 
Permission was granted by the Austrian Federal Ministry of Science, Research and Economy 
(identification code: BMWFW 66.018/0010-WF/V/3b/2016). Mice were bred and maintained 
at the local animal facility in accordance IST Austria Ethical Committee or purchased from 
Charles River and maintained at the local animal facility in accordance with IST Austria Ethical 
Committee. CCL19-Cre mice were a kind gift from Burkhard Ludewig. 
 
Transgenic mouse lines used Abbreviation Purpose 
CCl19-Cre; mTmG FRC-mTmG mGFP labeling of FRCs 
CCl19-Cre; MADM-7 - Sparse GFP and tdTomato labeling of FRCs 
CCL19-Cre; Talin1 floxed FRCΔTalin1 Specific knockout of Talin1 in FRCs 
CCL19-Cre; Talin1 floxed; mTmG FRC-mTmGΔTalin1 Specific knockout of Talin1 in FRCs, mGFP 
labeling of FRCs 
PROX1-GFP - GFP labeling of LECs 
 
Immunization 
For immunization KLH protein (Sigma-Aldrich) was dissolved in PBS to 5mg/mL of and then 
mixed 1:1 with CFA (Sigma-Aldrich). Mice were anesthetized by isoflurane inhalation (IsoFlo, 
Abbott) upon which the immunization mixture was injected in footpads and flanks of draining 
popliteal, inguinal and brachial lymph nodes. Lymph nodes were harvested after various 
timepoint up to two weeks of induction of immunization to be used for histology or explant 
experiments. Alternatively mice were used for in vivo experiments. 
 
Lymphocyte cellularity manipulation treatments 
For cellularity manipulation experiments, mice were either i.v. injected with 100 µg α-CD62L 
(MEL14) (BioXCell), or i.p. injected with 1mg/kg FTY720 (Tocris). Control mice were injected 
with a similar volume of PBS. For experiments under homeostatic conditions, lymph nodes 
were analyzed after 24h, and for inflammatory conditions after four days. 
 
Parallel plate compression 
Explanted popliteal lymph nodes were cleaned from adipose tissue under a 
stereomicroscope and placed on a glass plate within the 37°C, RPMI 1640 (Invitrogen) filled 
incubation chamber of a MicroSquisher device (CellScale). Lymph nodes were oriented to 
have their long axis along the field of view of the camera. Compression was performed with 
a glass plate glued onto either a 0.304 or 0.408 mm diameter, respectively 40 GPa tungsten 
filaments with a length of 60mm. The glass slide on the compression probe was coated with 
Poly-HEMA (Sigma-Aldrich) to reduce sticking of the samples. The lymph nodes were then 
compressed by 25% of the initial height by lowering the upper plate down in a timespan of 
30 seconds. Lateral side-views of the lymph node were recorded up to 30-60 minutes after 
onset of the experiment, while resistant forces were measured on the upper plate. Length, 
height, contact area and curvature of the lymph node were then manually measured before 
compression, and at the equilibrium timepoints using Fiji. The recorded compression force 
together with the measured geometrical parameters were used to calculate the Young’s 
modulus, effective resistance, viscosity, volume, and elastic and viscous half-times and 
spring constants using a generalized Kelvin model211. This was done as following: 
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The force required to maintain a constant strain of 25% on the lymph nodes was measured 
over time (F(t)). As shown in Figure 3E , the force initially peaks and then follows a relaxation 
curve which can be fit by a double exponential decay curve. The simplest way to describe this 
bimodal dynamics is to incorporate two dashpots with constants μ1 and μ2, and two springs 
with k1 and k2 constants as in Forgacs et al.211. Approximately after 20 minutes, the system 
reaches a steady state where the exerted force by the plate equals the effective resistance of 
the lymph node (σ). Therefore, we have: 








where Feq is the equilibrium force at steady state and R1, R2 and R3 are derived from the 
geometry of the lymph node as in the Figure 3D.  
 
To obtain the elastic modulus, the stress and strain need to be acquired: 
Stress (s) is calculated from the force at equilibrium divided by plate contact area: 
𝑠𝑠 = 𝐹𝐹𝑒𝑒𝑒𝑒/𝜋𝜋𝑅𝑅32 
 





where h0 and heq correspond to the initial and equilibrium height of the compressed lymph 
node. From here the elastic modulus (E) can be derived: 
 
𝐸𝐸 = 𝑠𝑠/𝜀𝜀 
 
Next, by fitting a double exponential decay to the force curve we obtain two time scales, τ1 
and τ2, where: 
𝜏𝜏𝑖𝑖 =  
𝜇𝜇𝑖𝑖
𝑘𝑘𝑖𝑖�
   , 𝑖𝑖 = 1, 2 
 
Following up on the derivations of the equations as in Forgacs et al.211, μ1 and μ2 can be 
acquired readily, where μ1 corresponds to the initial fast response in the order of seconds and 
μ2 to the slower response in the order of minutes, of which the latter one becomes relevant 
for the rearrangements of the cells within lymph nodes. Hence, we use μ2 as our viscosity. 
 
UV-laser cutter setup 
The UV-laser cutter setup is based on a previously described layout215,232. Briefly, a passively 
Q-switched solid-state 355nm UV-A laser (Powerchip, Teem Photonics) with a repetition rate 
of 1 kHZ, pulse energy of 15µJ, pulse-length of <350ps and peak-power of 40KW was used in 
conjugation with a spinning disc microscope (Axio Observer Z1, Zeiss). The system is 
controlled using custom-built software (LabView), National Instruments) enabling cutting in 
3D. Typically 5% of the power is used to cut tissues. 
 
UV-laser ablation 
Tension on FRCs, fLECs and the lymph node capsule was measured by conducting laser 
ablations on an inverted UV-laser ablation setup with a manufacturer 40x 1.2NA water 
immersion lens in homeostatic and inflamed lymph nodes. For FRC and fLEC ablation, inguinal 
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lymph nodes of CCL19-cre hem; mTmG hom mice were exposed using a skin flap surgery. The 
paracortical site of the lymph node was mounted on a custom made stage which allowed the 
temperature to be regulated at 37°C. For capsule ablation, popliteal and inguinal lymph nodes 
were harvested and incubated in 100uM TAMRA in RPMI 1640 solution (both Invitrogen) for 
15 min at RT and directly used for experiments. Explanted lymph nodes were mounted at 
room temperature in a glass bottom Petri dish (MatTek) in RPMI and prevented from floating 
using a 22x22mm cover glass topping. For all experiments 25 UV pulses at 1000 Hz to 40 
equidistant sites using 200ms exposure time and frame rate were used to ablate and capture 
tissue recoil. Cuts were performed in three z-planes spaced 1um apart along a length of either 
10 µm for FRCs, and in one z-plane along 20um for fLECs and capsule cuts. FRC cuts were 
typically performed at 10-20 µm depth. Recoil of FRCs and fLECs was quantified from 
kymographs made in FIJI, while capsule recoil was quantified using PIVlab in Matlab. In the 
latter case temporal recoil velocities were measured between bandpass filtered pre- and 
consecutive post-cut frames by averaging the component of the calculated velocity in the 
perpendicular direction to the cut, within an area of the surrounding cut site. 
 
SEM sample preparation 
Terminally ketamine anaesthetized mice were transcardially perfused using 0.1M PB (pH 7.4) 
and subsequent 2.5% glutaraldehyde and 2% paraformaldehyde (Science Services) in 0.1M 
PB. Upon perfusion fixation lymph node samples were dehydrated in a graded ethanol series 
of 50%, 70%, 90%, 96%, 100% in H2O for a minimum of 10 minutes per step and subsequently 
kept overnight in fresh 100% ethanol at 4°C. Once in 100% ethanol, samples were dried with 
a critical point dryer (EM-CPD300, Leica Microsystems) and afterwards coated with a 4nm 
layer of platinum using a sputter coater (EM-ACE600, Leica Microsystems). The samples were 
imaged with a field emission scanning electron microscope Merlin compact VP (Carl Zeiss) at 
1.5kV or 3 kV. The signal was detected by an Everhart-Thornley type secondary electron 
detector.  
 
Histology sample preparation 
Mouse tissues were harvested at indicated time points, fixed in 4% paraformaldehyde 
(Electron Microscopy Sciences) in PB (0.1M, pH 7) at 4°C overnight. For cryosections, tissues 
were additionally embedded for 24h in a solution of 30% glucose in 0.1M PB before 
embedding and freezing in Tissue-Tek optimum cutting temperature (OCT) compound 
(Sakura). Cryostat section (10-12 um) were collected on Superfrost/Plus glass slides (Thermo 
Fisher Scientific). Alternatively fixed tissues were embedded in 4% low melting temperature 
agarose (Invitrogen) after fixation and 100-200 µm sections were cut using a vibratome 
(VT1200S, Leica). 
 
Staining and imaging 
Cryostat sections were air-dried for 2h at RT and washed in PBS. Sections were blocked in 
SEABLOCK blocking buffer (Thermo Fischer Fisher Scientific), or in 5% bovine serum albumin 
(BSA) (Thermo Fisher Scientific) in PBS for 1h, followed by incubation of primary antibody 
solution diluted in 1%BSA/PBS for 1.5h at RT, 3 washing steps in PBS and subsequent 
incubation of secondary antibody solution diluted in 1%BSA/PBS for 30 min at RT. Finally 
sections were washed three times in PBS, air-dried and mounted using Fluoromount-G with 
DAPI (Thermo Fisher Scientific). Vibratome sections were blocked in 5% BSA/0.3%Triton-
x/PBS for 2h at RT under agitation followed by primary antibody incubation in 1% 
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BSA/0.3%Triton-x/PBS overnight at 4°C under agitation. The following day sections were 
washed three times in PBS and incubated in secondary antibody incubation in 1% 
BSA/0.3%Triton-x/PBS for 4h at RT under mild agitation. Sections were washed three times in 
PBS, incubated in DAPI solution for 15 minutes and mounted on a glass slide using 
Fluoromount-G (Thermo Fisher Scientific). The following primary antibodies were used: α-
CD3ε AF488 (OKT3)(eBioscience), α-B220-biotin (RA3-6B2) (eBioscience), α-ERTR7 (Abcam), 
α-CCL21 (BAF457) (R&D Systems), α-PDPN-biotin (8.1.1) (eBioscience), α-LYVE-1-biotin 
(BAF2125) (R&D Systems), α-PDGFR-β (AF1042) (R&D Systems), α-YAP/TAZ (D24E4) (Cell 
Signal), α-ICAM-1 (YN1/1.7.4) (BioXCell), α-VCAM (AF643-SP) (R&D Systems). α-MECA79 
(IgM) was derived from a concentrated hybridoma supernatant (kind gift from Christine 
Moussion). The following secondary antibodies were used: streptavidin-Cy3 (Sigma-Aldrich), 
streptavidin-AF647 (Jackson), goat α-mouse IgM AF647 (Invitrogen), donkey α-rabbit AF647 
(Jackson), chicken α-goat AF488 (Invitrogen), donkey α-rat AF647 (Invitrogen). Images were 
acquired on a Zeiss LSM800 inverted confocal laser scanning microscope. 
 
Three-dimensional light sheet fluorescence microscopy imaging (LSFMI) 
Terminally anesthetized CCL19-cre hem MADM-7 GT/TG mice (mix C57BL/6 and CD1 
background) were in vivo stained by retro-orbital injection of 40ug/PBS mouse α-peripheral 
node addressin (PNAd)-Atto-647N (Atto-Tec) concentrated hybridoma supernatant (kind gift 
from Christine Moussion). After 10 minutes, homeostatic or inflamed popliteal lymph nodes 
were harvested and fixed in 4% paraformaldehyde (Electron Microscopy Sciences) at 4°C 
overnight. Samples were cleaned under a stereomicroscope and incubated in CUBIC reagent 
1 for 3d at 37°C, which was replaced every 24h. Lymph nodes were then washed with PBS, 
embedded in 2% low-meting temperature agarose (Sigma-Aldrich), and sequentially 
dehydrated in 30% sucrose(Sigma-Aldrich) (1 day at 4°C) and 50% sucrose (2 days at 4°C). 
Finally samples were incubated in CUBIC reagent 2 for 2 days at RT. Cleared samples were 
imaged using a custom LSFM setup233. Acquired images were stitched using the FIJI 
Grid/Collection-stitching plugin (Preibitsch Laboratory), despeckled and registered using a 
custom-alignment-tool in Matlab (developed by Ekaterina Papusheva). 
 
Cluster Analysis on LSFMI data 
MADM labeled cells were detected in 3D by employing a spot detection algorithm (Imaris) for 
each channel separately. Chromatic aberrations and the sequential nature of the image 
acquisition lead to a channel misalignment which was corrected for in the following way: the 
spot coordinates were exported from Imaris and treated as a point cloud for each channel in 
Matlab. These point clouds were then registered onto each other using the Iterative closest 
point algorithm which corrected the shift and the rotation of the spectral channels. Cells were 
then sorted into color classes (green, red or yellow lineage). Red or green, If the spot existed 
solely in one of the point clouds, or yellow if there were two corresponding spots in both 
channels that are closer than the typical cell radius. 
 
For the cluster analysis the lymph node outline and the HEVs were segmented in Imaris using 
the surface detection feature. To correct errors in the cell detection, falsely detected spots 
outside of the lymph node volume were excluded from further analysis. The following 
approach was used for extracting the clustering behavior: in order to avoid edge effects cells 
in a region (D0: 100 µm, D4:200 µm and D8:400 µm, respectively) from the surface of the 
lymph node were excluded. For the remaining cells, well inside the lymph node volume, the 
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average distance to the next n neighbors was calculated. This average distance was then 
compared to the same measure of randomly generated distributions of the same number of 
cells. To generate a random distribution, spots were placed into the same volume occupied 
by the real cells assuring no overlap with the HEV would occur. The ‘cluster factor’ was then 
calculated as the ratio of the average distances to the next n neighbors of the real cell 
distribution and of the random distributions. In numerical simulations, this measure proved 
robust against variations of size, shape, and cell numbers. Further analysis was performed 
exemplarily for n=5 since the final results depend only weakly on n and a cluster factor of 5 




Popliteal lymph node explants were cleared from fat and incubated for 10 min in a 1/100 
ERTR7-647 (Santa-Cruz) in RPMI 1640 (Invitrogen) to label the capsule. The lymph nodes were 
subsequently placed on 3% methylcellulose coated glass bottom Petri dishes (MatTek) in 
RPMI and kept at 37°C, while imaged on an inverted Leica SP5 microscope using a 20x, 0.7NA 
objective (Leica Microsystems). Local elasticity of the capsule was measured with a glass 
micropipette connected to a Microfluidic Flow Control System (Fluigent, Fluiwell), with 
negative pressure ranging from 7-750 Pa, a pressure accuracy of 7 Pa and change rate of 200 
Pa.s-1. The micropipette equipment was mounted on a motorized micromanipulator 
(Eppendorf, Transferman Nk2). Both systems were controlled by Dikeria software, Labview 
(National Instruments). A fire polished micropipette with an inner diameter of 15 µm and flat 
end (Biomedical instruments) was used for aspiration. The chosen diameter ensured that 
mainly the capsule was probed and not the underlying parenchyma. While localizing the 
lymph node capsule with the micropipette, the pressure inside the micropipette was kept at 
0 Pa. For measurements, a negative pressure of 750 Pa was applied, which resulted In the 
instantaneous aspiration of the capsule. This pressure was chosen as lower pressure regimes 
did not result in proper aspiration of the capsule. The tongue length of the capsule in the 
micropipette upon aspiration was manually measured in Fiji from acquired movies. The 







With 𝛥𝛥𝛥𝛥 being the pressure difference between micropipette and atmosphere, ℎ the height 
of the measured tongue, and 𝑑𝑑 the micropipette diameter. 
 
Capsule thickness measurements 
The thickness of capsules was measured in vibratome sections of PROX1-GFP or wt mice, 
stained for PDGFR-β and DAPI. The size of the capsule was then manually measured using Fiji 
at multiple locations and averaged per lymph node. 
 
Alkali maceration 
Alkali maceration of lymph nodes was performed as previously described234,235. Briefly, lymph 
nodes were isolated from 8-12 week old wt C57BL/6 mice and fixed in a 2.5% glutaraldehyde 
and 2% paraformaldehyde in 0.1M PB for a minimum of two weeks at 4°C. Samples were then 
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macerated in a 2.5M (10%w/v) NaOH solutions in H2O for 5 days at RT under mild agitation. 
Next sections were rinsed in H2O under mild agitation for one to two days until samples 
became pale. If results were not sufficient, the maceration step was repeated. 
 
Electron Tomography Sample Preparation 
Samples were treated with 0.5% tannic acid (w/v) in PB (0.1 M, pH 7.4) two times 1 h each 
with freshly prepared solutions, washed in PB and treated with aqueous 1% osmium tetroxide 
(w/v) for 30 min at 4 °C. Samples were contrast enhanced with aqueous 1% uranyl acetate 
(w/v) overnight at 4 °C and Walton´s lead aspartate for 30 min at 60 °C. Samples were then 
dehydrated in graded ethanol, infiltrated with anhydrous propylene oxide and embedded in 
hard-grade epoxy resin (Durcupan® ACM, Fluca). Samples were consecutively infiltrated with 
a 3:1 mixture of anhydrous acetone and Durcupan® for 1 h at 4°C, 1:1 aceton/Durcupan® for 
1.5 h at 4°C, 1:3 aceton/Durcupan® for 2 h at 4 °C and mere Durcupan® overnight at RT. 
Samples were transferred to BEEM capsules (EMS, 70020-B), filled with freshly prepared 
Durcupan® and cured for 48 h at 60 °C.  
 
Electron Tomography Imaging 
Semi-thin sections (400-500 nm) were cut using an UC7 ultramicrotome (Leica Microsystems) 
and collected onto formvar-coated 200-line bar grids + 1C/bar (Science Services, G200PB) and 
coated with evaporated carbon to a thickness of 8 nm. Grids were cut in half, mounted on a 
Half-Mesh High Tilt holder (Jeol, EM-21010/Z09291THTR) and observed under a JEM 2800 
transmission electron microscope (Jeol) operated at 200 kV in STEM bright-field mode. For 
recording of image tilt series, an automated system was used comprising the STEM Recorder 
V3 Vers. 3.2.8.0 and the STEM Magica Controller Vers. 0.9.8.1 (both System In Frontier Inc.). 
Images were collected at 2° intervals between +/-76° of single tilt axis. Magnification was 
x100k – x600k, image size 512x512.  
 
3D Conduit quantification 
Electron Tomography images were aligned by cross-correlation and 3D structure of area of 
interest computed by weighted back-projection using Composer software Vers. 3.0 (System 
In Frontier Inc.). A 3D gaussian blur filter and background subtraction (roling ball algorithm) 
was performed on the images in FIJI. The 3D image stacks were subsequently loaded into 
Imaris (Bitplane) and fibrils of conduits were manually traced using the Filament Tracer tool 
and exported to Matlab format using the Object Exporter. 
Filament fibrils were exported from Imaris as tracks. The overall orientation and curvature of 
the entire fibril bundle was approximated by fitting a cubic spline curve with four support 
points which minimized a hand-crafted cost function. This cost function penalizes the distance 
of the desired centerline to the tracks, the total curvature of the centerline and the difference 
in length between it and the fibril bundles and ensures that the support points are spaced 
evenly. In a few cases this spline curve was corrected by hand if it was found to not adequately 
represent the center line of the bundle. The alignment of the individual fibrils with respect to 
the centerline of the bundle was calculated in the following way: The spline centerline was 
interpolated in a continuous fashion and the 3d orientation was calculated. Likewise, the 
tracks of induvial fibrils were first smoothed to reduce tracing errors and the 3d orientation 
of each segment of the trace was calculated. The alignment between the fibril is then given 
by the cosine of the angle between the orientation of the segment and the orientation of the 
centerline at the point that is closest to the segment:  
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The straightness of the fibrils is given by ratio of the sum of the length the segments, i.e., the 
total track length and the distance between the start and the end of the track of the fibril.  
 
FRC network GAP analysis 
3D acquired image stacks of labeled FRCs were segmented using (Ilastik). The segmented 
result was then transformed into a binary image and noise was removed using a custom FIJI 
script that utilized a particle detection algorithm. Binarized 3D image-stacks were then used 
to measure the spacing (gaps) in the network by analyzing the pore-size distribution. The 
pore-size distribution was obtained analogously to the pore-size analysis described in Acton 
et al. 187. Starting with a disk size which corresponded to the maximum gap of the network, 
disks were consecutively positioned into fitting corresponding gaps of the network. The 
maximum disk size was determined from a distance transform of the segmented network. 
Once no more disks of the maximum size could be placed into gaps of the network, the disk 
size was reduced by one unit and the placement of the disks of reduced sized commenced. 
This way, the gaps in the network were consecutively filled with disks of decreasing size until 
the entirety of the gap area was filled.  
 
Statistical Analysis 
All statistical analyses were performed in GraphPad Prism 8. 
 
Software  
Fiji Schindelin et al., 
2012 
https://fiji.sc/ 
Imaris Bitplane https://imaris.oxinst.com/packages 










Ilastik Sommer et al., 
2011 
https://www.ilastik.org/ 
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3 The lymph node conduit system and the access of soluble information in 
the paracortex 
Lymph nodes perform two main functions which are closely related. First, lymph nodes play 
a key role in the initiation and support of the immune response, as has been discussed in the 
previous chapters. Second, lymph nodes are important in fluid homeostasis and filtering. This 
second function is the topic of investigation in this following chapter. 
Within the body, fluid is contained in one of two fluid compartments: the intracellular and 
the extracellular compartment236. The extracellular compartment is estimated to contain 
about one-third of all fluids and is made up of the plasma (blood), interstitial fluid (the fluid 
in the intercellular space of tissues) and transcellular fluids (functional compartment that 
represent fluid exchange between the intracellular and extracellular space). There is 
continuous exchange of fluids between the plasma and interstitium along capillaries. The rate 
of exchange of plasma into the interstitium is dictated by Starling forces across the capillary 
wall, which are determined by the fluid pressure between these compartments and the 
colloid osmotic pressure237,238. This forms an excess of fluids in the interstitium that needs to 
be transported via lymphatic vessels back into the blood circulation. Failure to do so leads to 
the formation of edema239,240. Fluid ingress by lymphatic vessels occurs without significant 
hydrostatic pressure differences or colloid osmotic pressure between the interstitium and 
lymphatic content. Intermittent opening and closing of lymphatic valves are driving the net 
fluid ingress241. Lymphatic drainage results in a hydrostatic pressure in the peripheral 
interstitium that is negative compared to atmospheric pressures, further limiting the 
movement of fluids in the interstitium242.  
Fluids are constantly drained via lymphatics from the periphery into the lymph node, where 
they eventually find their way back into the blood circulation. Lymph nodes are therefore 
important in regulating interstitial fluid at the systemic level. Lymph can be returned to the 
blood circulation via two routes. Lymph can be either directly shunted into the blood 
circulation via intranodal lymph-venous shunts, or via a longer route where lymph is 
transported via the SCS into efferent lymphatics to the next lymph node in the chain, 
eventually draining into a collecting lymphatic duct that empties in the blood circulation 
(Figure 17) 241,243. The filtering function of the lymph node entails that small and large 
molecules are distributed via different routes in the lymph node and determines which cells 
have access to them. This connects the fluid homeostasis directly to immune surveillance and 
initiation of adaptive immunity: lymph contains a sample of peripheral tissues which include 
small and large particulate solutes that can contain e.g., antigens, viruses and bacteria. These 
solute particulates are encountered by differentially located subsets of APCs in the lymph 
node and can shape the immune response83. In this chapter I will discuss the filter function of 




Figure 17. Routes of systemic fluid transport via the blood and lymph circulation. 
Image adapted from Moore et al. 241. 
3.1 Lymph node filter function 
The essence of the lymph node filter has been briefly discussed in chapter one (Figure 2). 
Filtration occurs at the level of the SCS, where the sLECs express the PVLAP protein which 
functions as a molecular sieve that allows molecules of ~70kDa to enter the conduit strand 
and to be transported into the underlying parenchyma. Without PVLAP, the transport is 
limited by the tight floor of the SCS. Larger molecules will flow via the SCS to the medullary 
sinuses and are drained via efferent lymphatics109,244. Most of the fluid (~90%) will go via the 
SCS, while the rest is passing the SCS supposedly via conduits, leading to an effective clearance 
capacity when afferent and efferent lymph are compared245. In this chapter, the route via the 
conduit system in the parenchyma and its historical context will be discussed further. 
3.2 Conduits: a privileged site of soluble information? 
The reticular organization and capacity of fluid transfer through the parenchyma of the lymph 
node has been appreciated over many decades ago, where it was recognized that fluid tracers 
can move from outside the lymph node into the parenchyma via reticular structures towards  
high endothelial venules243,246-248. These initial anatomical and functional observations later 
resulted in current concepts on fluid perfusion and retention in the conduits and implications 
for the immune response. Soluble immunological mediators transferred by conduits include 
cytokines, chemokines and antigens that are important for immunological functions244,249. 
Histological evaluation of tracer studies showed a selective localization in conduits in the 
paracortex and further strengthened the idea that conduits are the main routes of soluble 
information delivery within the paracortex250,251. Functionally, information coming via the 
lymph and flowing to HEVs has been described to enhance trafficking of immune cells via 
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these blood vessels252. Two studies addressed how the information flow via the conduits is 
implicated in antigen delivery. One study described that skin-derived DCs residing in the 
lymph node are the first cells to acquire antigen following subcutaneous injection and are the 
first cells to present antigens to resident T cells79. A second study described that conduit-
associated resident APCs are able to take up antigen from the conduits80. This further 
established the idea that conduits are privileged sites for delivery of soluble information and 
that conduits are a closed system with no or limited passive exchange of soluble information 
between the conduit and lymphocyte compartment253,254. In line with this conduit paradigm, 
by using intravital imaging it has been shown that B cells effectively take up subcutaneously 
delivered antigens from sparse follicular conduits, but conversely the authors also observed 
that this can happen in a conduit independent manner255. More recent work shows that 
antigens can form steep gradients over the SCS floor into the parenchyma and the transport 
rapidly declines over time: although conduits initially permit antigen transport to the deep 
paracortex, conduit-independent antigen dispersal is the main mode of antigen delivery55,83. 
These results effectively put the concept of the closed conduit compartment and their role in 
soluble information delivery to rest and illustrate that bulk flow through the lymph node is 
happening. However, the idea of the conduit as a closed system and privileged site for soluble 
information transfer still persists. This is illustrated by recent reports that, based on histology, 
suggest that B cells secrete antibodies into conduits to facilitate their systemic distribution256, 
virion spread is mediated via conduit flows257, and even that the elastin component of the 
conduit might be important in mediating information flow258. Definite functional evidence 
whether conduits are an open or closed system and what is the importance of antigen uptake 
from conduits is still missing. 
3.3 Aims 
In this study the discrepancies between histological and in vivo functional evaluation of tracer 
injection experiments, as historically observed, were investigated. Furthermore, the 3D 
organization of cells surrounding the conduit were analyzed to obtain a better picture of how 
and to what extent cells are in contact with conduits. The most recent information stems from 
a study three decades old where it was estimated that conduits are for 90% covered by FRCs, 
while the rest is covered by immune cells. This was based on analysis of 2D transmission 
electron microscopy (TEM) sections121. Conduits are about 500 nm in diameter and cellular 
protrusion can be even thinner, in the order of tens of nm. Light microscopic evaluation is 
therefore not sufficient to accurately address the 3D organization of cells surrounding the 
conduit. To this end, we employed an array tomography for 3D SEM reconstruction approach. 
This entails the automatic collection of serial thin sections that are subsequently scanned with 
a large field of view (FOV) in ultra-resolution. This results in a 3D data-stack in which the 






Our observations show major discrepancies when subcutaneously injected tracer is observed 
in lymph nodes by histology or intravital microscopy (Figure 18). Following footpad injection 
of FITC Dextran (40kDa), differences in signal intensities in conduits and between lymphocytes 
arise between histological evaluation and in vivo imaging (Figure 18A,C). Histological 
evaluation shows a high tracer signal inside conduits, while a signal between lymphocytes can 
only be observed following the narrowing of the dynamic range of the tracer signal intensity 
(Figure 18A). In vivo imaging of injected tracer shows a different picture: the tracer signal in 
between lymphocytes is brighter compared to histology (Figure 18B, C). Furthermore, we see 
evidence of gradients forming through the subcapsular sinus (Figure 18B), in line with 
previous reports55,83. These observations show that conduits are not the main mode of 
soluble information transfer in the lymph node parenchyma as additional bulk flow is 
happening. Therefore, the observed differences in tracer localization are likely the result of a 
fixation artefact. Tracers in the form of fixable dextrans and fluorescently labeled proteins are 
more likely to be fixed at sites of extracellular matrix than between cells, where less cross-
linking is possible and results in high signals at the location of conduits and low signals 
between lymphocytes. In vivo imaging of injected tracers shows brighter signals mostly in 
conduits, likely the consequence of more free space than compared to the densely packed 
intercellular lymphocyte space. We observed that immune cells took up tracers from conduits 
(Figure 18C,D). Hence, conduits might still be a favorable place to acquire soluble information, 
but instead of being a closed system, conduits might function more as a river-delta forming 
paths of least resistance and collecting soluble information. To understand how soluble 
information is exchanged in the parenchyma, a better understanding of the cellular 
compartment around the conduit is necessary in combination with better in vivo tracer 
experiments that would directly show diffusion and convection in the steady state lymph 
node. 
To obtain high quality data for 3D SEM reconstruction, we optimized the workflow to process 
samples and obtain annotated cells for 3D reconstruction (Figure 19). Lymph node samples 
were prepared as illustrated in Figure 19. Mice were transcardially perfused with fixative to 
maintain native cell morphology of the tissue and enhance tissue integrity. This was followed 
by embedding, contrasting and collection of sections on a substrate. As manual sample 
collection can be tedious and sections can be easily damaged or lost, we used an automatic 
sample cutter and collector, allowing us to collect 181 consecutive sections of 50 nm thickness 
on a silicon substrate. 
 
Next, sections were acquired by SEM using dedicated software for array tomography, and 
were aligned, reconstructed and annotated by custom scripts, and open- and commercial 
software (Figure 19B). The acquisition involved first an overview to be taken from the ribbons 
of consecutive sections, followed by a low magnification scan to identify individual sections 
(Figure 19C). A high magnification scan was made from a few sections and an area of interest 
was chosen. The area of interest was then automatically copied onto all individual sections 
and high-resolution scans of this area on all sections were acquired (Figure 19C). Following 
processing and further cropping of the area of interest, we ended up with a tissue block that 
was used for manual annotation of cells (Figure 19C,D).  
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Figure 18. Comparison of histological or in vivo evaluation of tracer injections.  
A-D, Tracer studies of footpad injected FITC-Dextran 40kDa. Conduits are labeled with ERTR7-AF647 by injection 
into footpads the day before imaging. Draining popliteal lymph nodes were analyzed. Scale bars A-C = 20 µm, D 
= 10 µm. A, Histological evaluation of injected tracer. Lymph node was harvested after 15 min and directly fixed. 
Conduits contain high tracer signal, while signals between lymphocytes are seen only when the dynamic range 
is narrowed. B, In vivo imaging of tracer injection. A steep gradient from the capsule can be observed into the 
parenchyma. C, In vivo imaging of tracer injection. Signals in between lymphocytes is higher compared to 
histological samples. Signals in most conduits are higher than in between lymphocytes. Blue asterisks in the 
zoomed image indicate lymphocytes l ining a conduit that have taken up tracer. D, Example of tracer uptake by 
a lymphocyte (blue arrow) and DC (red arrow) in contact with a conduit. 
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After processing the sections and data, a conduit ring unit was annotated in 3D and all cells 
in contact with the conduit were individually annotated. Annotated cells and conduits 
(objects), and the 3D SEM stack were exported and scaled to obtain isotropic voxels (50nm3). 
Further, automatic alignment using a SURF feature algorithm was performed on all objects 
and the 3D SEM stack. This allowed us to create a 3D view of the conduit and lining FRCs, 
DCs/MΦs, and lymphocytes (Figure 20A,B). FRCs are lining most of the conduits and have a 
flat morphology (Figure 20A, B). DCs/MΦs are also associated with conduits and have a more 
bulky phenotype in which protrusions enwrap both the ‘naked’ and FRC lining conduit, 
forming an intricate connection with FRCs (Figure 20A-C). 
 
To quantify how much of the conduit is covered by the annotated cell types, we calculated 
the contact areas of cells with the conduit. This was achieved by calculating the distance from 
all surface points of all annotated cells to each voxel of the conduit surface. Cells were being 
considered in contact with conduits only when parts of their surface where directly adjacent 
to the conduit. In total 94% (322 µm2) of the reconstructed conduit surface area was 
annotated for contacting cells, and all percentages of contact area were normalized to this 
value. 
 
We found that 73.64% of all conduit surface area is being covered by FRCs (Figure 20A-D). 
With 25.57%, DCs/MΦs are the second largest population to cover the conduit (Figure 20A-
D). Together, FRCs and DCs/MΦs cover 99.21% of the total surface area of the conduit, leaving 
only sparse gaps available for lymphocytes, which cover only 0.79% of all conduits (Figure 
20A-D). These locations often appear at the interface where FRCs and DCs/MΦs are covering 
the contact area (Figure 20A-C). Taken together, we show that the conduit (about 500 nm in 
diameter) has a previously unappreciated complex coverage pattern of different cell types 
(Figure 20C,D). Furthermore, 3D reconstructions show an intricate relationship between 




Figure 19. Workflow of data acquisition for 3D SEM reconstruction.  
A, Schematic workflow for sample preparation. Schematics adapted from Deerinck et al. 260 B, Schematic 
workflow for acquisition and data processing. C, Detailed overview of acquisition procedure and scanning 
parameters. D, Results of a 3D cropped region of interest used for annotation of cells. Voxel size was made 





Figure 20. 3D reconstruction of annotated conduits and cells.  
A, Left: 3D reconstruction of conduit (dark gray) and FRCs (various colors). Right: same view but with DCs/MΦs 
added on top (various colors). Scale bars = 500 nm. B, Top view of 3D reconstruction. Left: conduit (dark gray) 
and FRCs (various colors), Middle: conduit (dark gray) and DCs/MΦs (various colors), conduit (dark gray), FRCs 
and DCs/MΦs (various colors), and lymphocytes (transparent, various colors). Scale bars = 700 nm. C, Left, 
middle: 3D reconstruction of a DC/MΦ (cyan) and its nucleus (red), sitting on and enwrapping a conduit (gray). 







Figure 21. Contact areas with conduits. 
A, 3D reconstruction of contact areas (various colors) with conduit (dark grey) per cell  type, and combined. B, 
3D reconstruction of contact areas (various colors) with conduit (dark gray) per cell, and combined. C, Close up 
of contact areas (various colors) with conduit (dark gray) per cell, and combined. D, Quantification of conduit 




In this study, we show for the first time the complex 3D organization of cells surrounding the 
conduit network of the lymph node. Our results have further implications for understanding 
the role of conduits in fluid flow through the parenchyma. Previous estimates made from 2D 
TEM sections estimated that conduits are for 90% covered by FRCs121. We show with a high 
accuracy approach that FRCs are covering only 74% of the conduit surface. These differences 
could emerge from the higher accuracy of our approach or from local differences of conduit 
coverage within the lymph node. Furthermore, we found that more than 99% of the conduit 
surface is covered by FRCs and DCs/MΦs, leaving only little spaces uncovered which are 
occupied by lymphocytes. It is therefore unclear whether FRCs and DCs/MΦs form a tight 
coverage of the conduit that does not allow exchange from inside and outside the conduit, or 
whether passive or active transcellular fluid exchange mechanisms exist. This soluble 
information exchange at the conduit level, as well as possible experiments to address open 
questions, will be further discussed here. 
 
The most direct read out of soluble information exchange between the inside and outside of 
the conduit can be achieved by using photo-activatable proteins or caged fluorophores. These 
can be injected in mice and switched from a dark state to bright state using light of a specific 
wavelength. These tracers can be switched to an activated bright state at spatially defined 
locations, e.g. inside or outside the conduit and followed by imaging over time. This would 
address the soluble information exchange surrounding the conduit: If conduits are indeed a 
tight system, the activated signal would stay mainly within the conduit, as opposed to leaking 
out. When such tracers are activated outside the conduit between the lymphocyte space, the 
signal can be followed to either enter the conduit system or stay restricted in space outside 
of the conduits. These experiments should be able to address if the conduit system is indeed 
a closed system or if it functions more like a river delta, forming paths of least resistance. 
It is unknown if conduits are important mediators for taking up soluble information by 
immune cells. Although reports indicate that bulk flow is observed following injection of 
tracers and DCs are able to take up antigens when not in contact with conduits, no direct 
proof is available to which extent taking up soluble information from conduits is 
physiologically relevant83,254. A situation in which half of the conduit-associated DCs/ MΦs are 
dissociated from the conduit is useful, as it allows a tracer uptake competition experiment 
within the same lymph node. Such a situation can be generated by creating mixed bone 
marrow chimeras from CX3CR1-GFP and CX3CR1-CAG-tdTomatoΔTalin1 mice. The CX3CR1 
targets the conduit associated resident MΦs122. Knockout of talin1 dissociates the MΦs from 
the conduits by interfering with their binding, but would still localize them to the correct 
anatomical location in the lymph node (unreported observation). Furthermore, knockouts will 
express tdTomato to distinguish them from control GFP+ MΦs. Together the competition 
experiment would teach us whether information uptake from conduits is more efficient that 
from bulk flow in between lymphocytes. 
Tracer studies might have some unappreciated drawbacks associated with them. These 
studies are often performed by injection of a 10-20 µL solution into the footpad of mice. Such 
volumes are relatively large compared to the footpad and can create some artefacts. 
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Moreover, swift injection is likely to produce high pressures through the use of high Gauge 
needles, and could artificially push more fluid into lymphatic system than is likely to happen 
physiologically. Together, this could mean that upon injection of a tracer the time to reach 
the lymph node (around 30 seconds) might be an artefact resulting from the injection itself 
and not representing the actual physiological transport rate. More sophisticated injection 
experiments, in which the injection rate can be carefully controlled are therefore necessary.  
 
Tracer injections could importantly affect hydrostatic pressures in the lymph node and 
interfere with bulk flow. No data is available on hydrostatic pressures in the lymph nodes, 
though most of the body’s interstitium has a negative pressure compared to the atmosphere. 
Lymph nodes with their medullary lymphatics can produce a similar situation as in peripheral 
skin, and it is therefore not unreasonable to believe that negative hydrostatic pressures exist 
in the lymph node parenchyma. This has important implications: negative pressures limit 
movement of fluids, arguing against bulk flow in the lymph node242. However, a small increase 
in volume can easily increase hydrostatic pressures (highly non-linear effect242), and if tracer 
injections indeed cause artefacts by increasing the volume and hydrostatic pressure 
temporarily, this could result in bulk flow. Perhaps such bulk flow could be the cause of steep 
gradient formation from the SCS to the parenchyma, which might be or might not be 
physiological. Experiments in which the hydrostatic pressure of the lymph node is measured 
over time following tracer injections are therefore recommended. It is likely that slow 
injection rates would have minimal effects on the hydrostatic pressure in the lymph node and 





3.6 Materials and methods 
Animals 
All animal experiments are in accordance with the Austrian law for animal experiments. 
Permission was granted by the Austrian Federal Ministry of Science, Research and Economy 
(identification code: BMWFW 66.018/0010-WF/V/3b/2016). Mice were bred and maintained 
at the local animal facility in accordance IST Austria Ethical Committee or purchased from 




Wt C57BL/6 mice (8-14 weeks of age) were anesthetized by isoflurane inhalation (IsoFlo, 
Abbott) upon which 10 µL of 40kDa FITC-dextran (5mg/mL in PBS) was injected into the 
footpad. For in vivo imaging the FITC-dextran solution was injected into the footpad shortly 
before imaging. 
 
Histology and imaging 
The draining popliteal lymph node was harvested after 15 minutes and fixed in 4%PFA 
(Electron Microscopy Sciences) in PB (0.1M, pH 7) at 4 °C overnight. Fixed tissues were 
embedded in 4% low melting temperature agarose (Invitrogen) after fixation and 100-200 µm 
sections were cut using a vibratome (VT1200S, Leica). Vibratome sections were blocked in 5% 
BSA/0.3%Triton-x/PBS for 2h at room temperature (RT) under agitation, followed by FRC 
staining with α-PDPN-biotin (8.1.1) (eBioscience) in 1% BSA/0.3%Triton-x/PBS and incubated 
overnight at 4 °C s under agitation. The following day sections were washed three times in 
PBS and incubated in streptavidin-Cy3 (Sigma-Aldrich) secondary antibody in 1% 
BSA/0.3%Triton-x/PBS for 4h at RT under mild agitation. Sections were washed three times in 
PBS, incubated in DAPI solution and mounted on a glass slide using Fluoromount-G (Thermo 
Fisher Scientific). Images were acquired on a Zeiss LSM800 inverted confocal laser scanning 
microscope. 
 
In vivo imaging 
For in vivo imaging of tracers, wt mice were anesthetized with an intraperitoneal injection of 
ketamine, xylazine and acepromazine, and the popliteal lymph node surgically exposed for 
imaging, as previously described97,259. To label conduits, 3μg ERTR7-AF647 (Santa-Cruz) was 
injected into the footpads of mice the day before surgery. Time-lapse movies of tracer 
injections were recorded either with a confocal microscope (Zeiss LSM880 upright equipped 
with a 20X water immersion lens) or with a TriM Scope multi-photon microscope (LaVision 
BioTec), which is equipped with a multi-photon laser (Chameleon from Coherent) set to 
840 nm for exciting the tracer and an OPO laser set to 1150 nm for exciting ERTR7-AF647 
labeled conduits. A 20x water immersion lens was used to acquire time-lapse movies. Images 
with a 241x241 μm FOV, and a resolution of 512x512 pixels were acquired every 10 seconds 
at 8 different z-slices, spaced 3 μm apart. For the antigen uptake movie an area around an 
HEV was imaged with a 102x102 μm FOV, and a resolution of 512x512 pixels, and was 
acquired every 20 seconds at 9 different z-slices, spaced 2 μm apart. For confocal imaging a 





Fixation and embedding 
We followed the OTO fixation protocol after Deerinck et. Al. to enhance the contrast of the 
tissue for SEM260. C57BL/6 mice, 8-12 weeks old, were anesthetized with an intraperitoneal 
injection of ketamine, xylazine and acepromazin and perfused transcardially with 0.025M 
phosphate buffered (PB) (pH 7.4) for 2 min, followed by a fixative solution of 2% 
paraformaldehyde and 2.5% glutaraldehyde (Science Services) in 0.1M PB. Immediately after 
perfusion popliteal lymph nodes were harvested and post-fixed for another 2h at RT. The 
samples were washed in 0.1M PB and subsequently contrast enhanced in 2% aqueous 
osmium tetroxide (Science Services) and 1.5% potassium ferrocyanide (Sigma-Aldrich) in 
0.1M PB for 1h on ice in the dark. After washing with MilliQ water, the lymph nodes were 
transferred in thiocarbohydrazide (Sigma-Aldrich) for 20 min at RT and then again washed 
with MilliQ water. Samples were placed in 2% aqueous osmium tetroxide for 30 min at RT in 
the dark and again washed with MilliQ water. Next, samples were incubated overnight in 1% 
aqueous uranyl acetate (AL-Labortechnik) at 4°C. Samples were then washed in MilliQ water, 
placed in Walton’s lead aspartate solution (Sigma-Aldrich) for 30 min at 60°C and washed in 
MilliQ water. The samples were dehydrated using a graded series of ethanol and then placed 
in anhydrous acetone. Afterwards samples were infiltrated in a graded series of hard 
DurcupanTM ACM resin (Sigma-Aldrich) in acetone. The samples were placed in pure Durcupan 
overnight and then transferred to BEEM capsules (Science Services) filled with fresh resin. For 
polymerization, samples were placed in a 60°C oven for 3 days.  
 
Sectioning and imaging 
The embedded samples were trimmed with an EM Trim2 (Leica Microsystems) using a 
diamond miller. Automated serial sectioning was performed with an EM UC7-Artos 3D 
microtome (Leica Microsystems). Three ribbons with a total number of 181 sections and a 
thickness of 50 nm were collected onto a 25x25 mm plasma-treated Si-wafer using the water 
drain device of the Leica AT-4 35° diamond knife (Diatome) (Kindly performed by Robert 
Ranner, Leica Microsystems). Then the dried Si-wafer with the section ribbons were coated 
with a 5nm carbon layer using the ACE 600 (Leica Microsystems). Sections were imaged with 
a scanning electron microscope (FE-SEM Merlin compact VP, Carl Zeiss) equipped with the 
Atlas 5 Array Tomography. The serial section images (5 nm pixel size) were acquired using an 
Everhart-Thornley type secondary electron detector at 5kV. 
 
Reconstruction and annotation 
3D reconstructions were performed as following: TrakEM2 plugin 
(https://imagej.net/TrakEM2) of Fiji was used to align the dataset by manually placing 
landmarks. Using TrakEm2 cells and conduits were manually annotate and exported as a 
binary image, along with the 3D SEM data stack. All images were subsequently downscaled 
to generate an isotropic voxel size (50nm3). A few defectively slices (3) were replaced by 
duplication of previous good slices. Further fine alignment was performed by finding 
corresponding landmarks is slices by extracting Speeded Up robust Features (SURF) features 
from consecutive SEM slices (image_Z, Image_Z+1). The geometric transformation that best 
links the SURF features of both images was estimated using a variant of random sample 
consensus algorithm (M-estimator sample Consensus (MSAC)). The best affine 
transformation T_Z was then applied to Image_Z+1. Subsequently the slice replacements and 
 80 
transformations T_Z were also applied to annotated image stacks. The brightness variations 
in the aligned SEM stack was corrected for by histogram equalization. 
Contact surface reconstruction 
The surface of all annotated objects (conduit and cells) was first smoothed by morphological  
closing with a radius of one voxel and then extracted performing binary erosion with the same 
radius. For each voxel of the conduit surface the distance to all surface points of all cells was 
calculated. The contact area of cells with the conduit was calculated as the number of voxels 
that are directly adjacent to the conduit i.e., with a distance smaller than √3 x the size of the 
voxel. The contact area calculation was repeated for larger threshold distances in case the 
manual labeling had been inadequate. However, the fractional contact areas did not depend 
on the exact threshold distance, confirming the quality of the labeling. 
Visualization 
The SEM stack, and exported and processed annotated cells, conduit, and contact surfaces 
were imported in Imaris (Bitplane). Isosurfaces were subsequently generated for each object 
for 3D visualization. 
Statistical Analysis 
All statistical analyses were performed in GraphPad Prism 8. 
Statement of contributions 
In vivo tracer injection experiments 
Surgical exposure of popliteal lymph nodes performed was by Miroslav Hons. Imaging and 
analysis were performed by the author of this thesis. 
SEM sample processing and imaging 
All sample preparations were performed by Vanessa Zheden. Cutting of consecutive sections 
performed by Robert Ranner. Imaging was done by Vanessa Zheden and the author. 
 
Reconstruction and annotation 
3D reconstructions were performed by the author. Annotation of cells performed by Anna 
Deart, Vanessa Zheden and the author. 
 
Quantification of contact surfaces 
Robert Hauschild wrote a script for the quantification of contact surfaces. Further analysis 
was done by the author. 
 
All other experiments and analyses not specifically stated above were performed by the 







4 Metastatic dissemination via lymph nodes 
 
The role of lymph nodes in metastatic dissemination of cancer cells has been heavily 
debated261,262. In essence, the core of the debate questions which anatomical routes cancer 
cells take to invade in foreign tissues and which routes can contribute to the formation of 
metastasis. The lymph node is an organ adapted for cells passing through, and constantly 
deals with trafficking of many types of immune cells entering and leaving the organ via 
different routes107,167. This means that it is possible for cancer cells to either directly enter the 
blood stream at the site of the primary tumor, or to utilize afferent lymphatics to enter the 
lymph node and disseminate from there. Considering the contribution of lymph nodes in 
metastatic dissemination, tumor cells can either follow the efferent lymphatic route, or enter 
the parenchyma and leave the lymph node via blood vessels. It is unknow which of these two 
options is occurring and to what extent these routes can contribute to the formation of distal 
metastatic lesions. The aim of this study was therefore to investigate the main route 
mammary carcinoma cells would take inside the lymph node, and address if systemic 
dissemination via the observed route can contribute to distal metastatic lesions in the 
absence of primary tumor contribution. We found that mammary carcinoma cells infused into 
the SCS of lymph nodes are rapidly migrating into the parenchyma where they localize with 
blood vessels. The mammary carcinoma cells are able to utilize these blood vessels to enter 
the blood circulation and form metastases in distal tissues. 
 
Statement of contribution 
For the manuscript I performed (parts) of the experiments for the following Figures: S1A, S1B, 
S6A, S7A, S7C. 
Additionally, I contributed to the following figures by parts of the data analysis, and by making 




4.1 Results – ‘Lymph node blood vessels provide exit routes for metastatic 








































































In this study a novel method of intra-lymphatic injection of tumor cells was used to deliver 
mammary carcinoma cells directly into the SCS of the draining popliteal lymph node, which 
closely recapitulated the situation in human patients. This method of pseudo-metastasis 
formation allowed to determine the contribution of such pseudo-metastasis in lymph nodes 
to the distal dissemination of cancer cells to lungs. Importantly, this has been done in the 
absence of a primary tumor, which would otherwise make interpretation of contribution 
more difficult. Furthermore, by timing the event of carcinoma cells invasion in lymph nodes, 
it was possible to efficiently dissect a timeline and route of dissemination. We demonstrated 
that the mammary carcinoma cells quickly find their way into the parenchyma where they 
associate with blood vessels. These cells were later found in the blood circulation and were 
able to form distal metastases in the lung. To confirm that the route of metastatic 
dissemination from lymph nodes is via blood vessels, efferent lymphatic vessels were ligated. 
This did not prevent formation of metastases in the lung, while lymphocytes (which take the 
efferent lymphatic route to exit the lymph node) in general failed to exit lymph nodes and 
reappear in blood circulation. Interestingly, a minor population of T-cells was able to 
recirculate to the spleen and medial iliac lymph nodes, suggesting that T-cells in mice have 
the capacity to rarely recirculate via lymph node blood vessels. 
 
These results could have important implications for human patients since treatment is 
focused on tumor cell infiltrates in draining lymph nodes, and determines if lymph nodes are 
resected or a breast area is irradiated263. This study suggest that irradiation of the breast area 
or dissection of lymph nodes might be beneficial for patients with mammary carcinoma and 
lymph node metastases. Importantly, it will be necessary for clinical studies to first 





The work in the here-presented thesis shows a role for the FRC network in lymph node 
swelling, and debates implications for fluid transfer in the lymph node based on 3D ultra-
structural reconstruction of the conduit interface. Furthermore, we investigated how 
mammary carcinoma cells hitchhike trafficking routes of immune cells to exit the organ and 
contribute to formation of distant metastases. 
 
We found that in the swelling lymph node, FRCs are locally proliferating in a spatially unbiased 
manner, which keeps the FRC network intact in the growing organ. Importantly we found that 
clustering of FRCs correlated well with lymph node size, underlining the tight regulation of 
FRC network expansion and lymph node swelling. We further addressed the role of a 
mechanical feedback mechanism that could regulate the lymph node size in homeostasis and 
inflammation by coordinating lymphocyte entry.  
 
By interfering with lymphocyte cellularity, we could conclude that there is a positive trend 
between lymphocyte numbers in the lymph node and resistance to swelling, both in 
homeostatic and inflammatory conditions. Further analysis of tension on FRCs showed that 
lymphocyte-induced tissue pressure results in higher tension on the FRC network. This 
implied that a mechanical feedback is likely to exist between FRC contractility and lymphocyte 
entry into the organ, which limits the swelling in inflammation. We could confirm this 
hypothesis by conditionally knocking out talin1 in FRCs, what lead to impaired 
mechanosensing and failure to increase tension in the swelling lymph node. Importantly, the 
lack of talin1 in FRCs resulted in a lower effective resistance and faster swelling kinetics, 
showing a direct link between a feedback mechanism of FRC contractility, resistance to 
swelling, and lymphocyte entry. This changes the current paradigm that continuous FRC 
relaxation is mainly important for driving the growth of the organ in inflammation187,188. 
However, it would still not explain fully how the lymph node is able to swell when FRC 
contractility leads to reduced lymphocyte entry. We therefore hypothesize that the lymph 
node grows in a dynamic interplay between FRC proliferation and lymphocyte entry. FRCs 
limit lymphocyte entry and expand the network according to the volumetric needs. This in 
turn reduces the resistance to swelling and allows more cells to enter the lymph node. Such 
a mechanism could explain how FRC network expansion and lymph node size are regulated. 
This is further supported by experiments on stroma lacking talin1, in which coordination 
between the FRC network and lymph node size is abolished. Moreover, we show that the 
capsule is actively being remodeled during inflammation. The capsule thickens and becomes 
more stiff, which is expected to be important in stopping the swelling of the lymph node and 
releasing tension of the FRC network.  
 
Together, our findings show an important, previously unrecognized role for the conduit and 
FRC network in mediating tension to coordinate the lymph node size in homeostasis and 
swelling rate in inflammation. This is essential for preserving the integrity of the FRC network 
and expected to have important implications in immune responses. Further work should 
focus on putative negative and positive mechanical feedback mechanisms of lymph node 
swelling. Lymphocyte homing experiments under differential resistant conditions (in which 
FRCs are either in a high or low contractile state) could demonstrate that higher FRC 
contractility affects lymph node swelling by restricting lymphocyte entry into the swelling 
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lymph node (negative feedback). In turn, mice of which their FRCs lack talin1 and have 
problems with mechanosensing could elucidate if sensing of high tension by FRCs promotes  
proliferation of these cells in the swelling lymph node, driving further expansion of the 
swelling lymph node (positive feedback).  
 
Furthermore, we investigated the role of the FRC/conduit network in transfer of soluble 
information. By high resolution 3D ultra-reconstruction we unraveled the cellular 
composition around the conduit. We found that more than 99% of the conduit is covered by 
FRCs and DCs/MΦs and less than 1% is uncovered and accessible to lymphocytes. This could 
have implications in how information is exchanged between conduits and surroundings, and 
could make conduits a favorable place for immune cells to sample soluble information. 
However, more work remains to be done to challenge the idea of conduits as a privileged site 
of information access. Future work should focus on experimental setups in which small 
volumes of tracers can be carefully injected without creating artificial pressures in the 
draining lymph node. Combined with in vivo imaging it can be established if conduits are 
important routes of small solutes transfer under physiological conditions. Moreover, 
competition experiments between conduit adherent MΦs and conduit-dissociated MΦs (MΦ 
lacking talin1) would elucidate if conduits are important places for the acquisition of small 
lymph-borne solutes. 
 
Finally, we show the role for lymph node blood vessels in dissemination of mammary 
carcinoma cells. Infused cancer cells use similar migration routes as immune cells. They enter 
the parenchyma by passing the subcapsular sinus and reside in lymph nodes in close contact 
with blood vessels. By ligating the lymphatic exit routes of the organ, we could demonstrate 
that cancer cells escape from lymph nodes via blood vessels, recirculate in blood and 
metastasize this way at distant sites. Those findings are an important contribution to an 
ongoing debate on the role of lymph node infiltrated cancer cells and their clinical significance 
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